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The interest in pulmonary vein development has rapidly increased since the 
role of the pulmonary venous myocardial sleeve in the foundation of potential 
atrial arrhythmias1,2 and the vulnerability for potential pathogenic processes3 
has become more and more clear. A more detailed understanding of normal and 
abnormal pulmonary vein development requires comprehension of general cardiac 
development, since the so-called heart fields, that play a very important role in 
the formation of the complete heart, play an essential role in the composition and 
differentiation of the pulmonary venous wall as well4. Abnormalities in this (vessel) 
wall composition as well as the presence and re-activation of embryonic cardiac 
conduction system cells can be responsible for the onset of arrhythmias1. Besides 
that, abnormal pulmonary vein development, leading to abnormal pulmonary vein 
anatomy, may be held responsible for a lot of clinical entities. 
Cardiac development
The primary heart tube develops from two parallel cardiogenic plates located in the 
anterior splanchnic mesoderm. After fusion of these crescent shaped cardiogenic 
plates in the midline, a primary myocardial heart tube is formed, cranially connected to 
the pharyngeal arches and caudally to the omphalomesenteric veins. The myocardial 
tube is lined on the inside by cardiac jelly (later on replaced by the endocardial 
cushions) and endocardial cells that are continuous with the endothelium of the 
embryonic vascular plexus5,6. This primary heart tube has an asymmetric shape as a 
consequence of predetermined left-right patterning and cardiac looping6-8. Cardiac 
differentiation into future atrial and ventricular components already takes place 
in the cardiogenic plate stage, based on expression of cardiac-specific genes like 
Nkx2.58 and GATA4-69. 
In normal development, the heart tube loops to the right, resulting in a position 
of the outflow tract frontal to the atria and wedging of the aorta in between 
the atrioventricular orifices. During heart development, cardiac chambers and 
transitional zones are distinguished, the latter being involved in cardiac septation, 
valve formation and development of the cardiac conduction system. There has been 
much debate about which heart segments are discernable in the primitive heart 




































an atrio-ventricular canal and a primitive left ventricle5,6. The splanchnic mesoderm 
forming the primary heart tube is referred to as the first heart field or first lineage, 
and has the potential to generate differentiation into myocardial cells10,11. To this 
primary myocardium, new myocardium is secondarily contributed (second lineage), 
recruited from the so-called second heart field, located in the splanchnic mesoderm 
dorsal to the primary tube (Fig.1)12. Islet 1 (Isl 1), a marker of undifferentiated cardiac 
progenitor cells, and inhibitor of DNA binding 2 (Id2) have shown that major parts of 
the arterial as well as the venous pole of the heart are derived from this second heart 
field13,14. Therefore, to simplify understanding of terms, processes at the arterial pole 
(outflow tract) and venous pole (inflow tract) will be described separately. 
Myocardial recruitment at the arterial pole
Several studies have been performed using different lineage markers such as fibroblast 
growth factor(Fgf)8 and 1015, Islet (Isl)113 and Tbx116 to trace these cells into their 
cardiac destination. As a result of this, we know that undifferentiated mesoderm, 
recruited from the anterior heart field, is responsible for addition of myocardium 
of the complete right ventricle and the proximal arterial outflow tract12,17, whereas 
the secondary heart field, being the distal part of the anterior heart field, forms the 
distal outflow tract18. Both the anterior heart field and the secondary heart field are 
part of the second heart field (Fig.1).
An extracardiac cell type contributive to the formation of the definitive heart at the 
arterial pole is the neural crest cell, derived from the crest of the neural tube18,19. At 
the arterial pole, these cells have an active role in the formation of the pharyngeal 
arch arteries and, to a lesser extent, in the septation of the outflow tract (Fig.1), since 
neural crest ablation has lead to cardiac outflow tract malformations19. Therefore, it 
is not surprising that a good interaction of both second heart field and neural crest 
cells is a prerequisite for the normal outflow tract development. 
Finally, besides genetic factors being the cause of cardiac anomalies, also epigenetic 
(environmental) factors can play a role in remodeling of the outflow tract, as seen in 






































Figure 1. Schematic representation of the first and second heart field contribution to cardiac development. 
The primary heart tube, which contains the left ventricle (LV), the atrioventricular canal (AVC) and parts of 
the atria, is derived from the Isl-1 negative precursors of the first heart field and is depicted in brown. The 
secondary added myocardium, derived from Isl-1 positive precursors of the second heart field, is depicted 
in yellow. The second heart field is divided into a secondary heart field, that contributes to the distal 
outflow tract (DOT) and an anterior heart field that contributes to the right ventricle (RV) and the proximal 
outflow tract (POT) at the arterial pole of the heart. At the venous pole of the heart, myocardium is 
added from the posterior heart field, which contributes to the posterior wall of the atria and the interatrial 
septum, the dorsal mesenchymal protrusion (DMP), the sinoatrial node (SAN), the myocardium of the 
sinus venosus (SV), the pulmonary veins (PV), and the cardinal veins (CV), including the coronary sinus 
(CS), and probably part of the central conduction system (CCS). The posterior heart field also contributes 
to the proepicardial organ (PEO), which is the source of the epicardium and epicardium derived cells. 
Cardiac neural crest cells (dark blue) migrate to the heart and enter the heart both at the arterial and 
venous pole. Inflow tract (IFT); ganglia (ggL); outflow tract (OFT); pharyngeal arch arteries (PAA). Adapted 




































Myocardial recruitment at the venous pole
Analogous to the arterial pole, there has been special interest for markers specific 
for recruitment of myocardium from the second heart field to the venous pole of the 
heart, such as Pitx2c24, Nkx2.524,25, Tbx1826, Shox227 and podoplanin25,28. This region 
of the second heart field, located posteriorly to the primary heart tube, is involved in 
the addition of myocardium to the sinus venosus area, including the sino-atrial node, 
the pulmonary veins, the cardinal veins and the coronary sinus, as well as the main 
body of the atria, and is referred to as the posterior heart field (Fig.1).
Moreover, at the venous pole, two other extracardiac cell types play a role in the 
formation of the definitive heart structures. In the first place, neural crest cells that 
migrate into the inflow tract29, are important for the development of the sympathic 
and parasypmpathic ganglia30, and possibly are the indication of the atrioventricular 
conduction system31. Secondly, epicardial cells that are derived from the coelomic 
epithelial lining (coelomic mesothelium) of the posterior heart field, forming the 
proepicardial organ (PEO)32-34 (Fig.1). Cells derived from this PEO grow out over the 
myocardial heart tube35 and undergo epithelial-to-mesenchymal transformation 
(EMT). The so-called epicardium-derived cells (EPDC’s)36-38 migrate into the atrial and 
ventricular myocardium and are essential for the formation of compact myocardium39, 
the atrioventricular valves36, the main coronary arteries40,41 and differentiation of 







































General pulmonary vein development 
During the fourth week of embryonic development, two primary lung buds can be 
discriminated at the caudal end of the respiratory diverticulum, that develop in the 
surrounding splanchnic mesenchyme43. Subsequently, these lung buds differentiate 
into the bronchi and their bifurcations in the future lungs. The cartilaginous plates, 
the bronchial smooth muscle and connective tissue as well as the pulmonary 
connective tissue and capillaries are derived from the splanchnic mesenchyme, that 
forms a plexus of veins, by which the primitive lungs drain to the systemic circulation. 
This splanchnic plexus is also connected to the endocardium of the primitive heart 
tube by means of a strand of endothelial cells, situated in the mesocardium behind 
the heart, which is the anlage of the future common pulmonary vein44 (Fig.2). When 
this strand lumenizes, initially, the lungs can drain centrally, to the atrial part of 
the heart, as well as peripherally, to the systemic veins. After atrial septation, the 
common pulmonary vein drains to the left atrium and starts to grow. The pulmonary-
to-systemic venous connections are not necessary anymore and regress45. Abnormal 
development of the common pulmonary vein might be related to persistence of 
the primitive pulmonary-to-systemic connections which is the likely substrate for 









































































Figure 2. Schematic depiction of pulmonary vein development.
a,b. Lateral (a) and frontal (b) view. The splanchnic vascular network surrounds the two lung buds (LB) and 
drains to the systemic circulation by means of primitive pulmonary-to-systemic connections to the right 
and left cardinal veins (RCV/LCV) or the right and left umbilical and vitelline veins (RUVV/LUVV). In the 
region of the heart, this splanchnic plexus (SP) is connected to the sinus venosus segment of the heart (SV, 
blue) by means of the midpharyngeal endothelial strand (MPES), which is the remaining part of a strand of 
endothelial cells that initially runs from the arterial to the venous pole in the dorsal mesocardium.
c. When the endothelial strand, which is the anlage of the future common pulmonary vein (CPV) 
lumenizes, the splanchnic plexus can drain its blood to the systemic circulation as well as to the heart. 
Although atrial septation has started, the CPV still drains to the sinus venosus segment that is connected 
to a common atrium.
 d. The CPV grows and dilates, becoming the main route for drainage of pulmonary venous blood. The 
primitive pulmonary-to-systemic connections are not necessary anymore and regress. After atrial 
septation has completed (IAS), the part of the sinus venosus containing the CPV is placed to the left, 
becoming part of the left atrium (LA).
e. The CPV has bifurcated, so that the right and left lung (RL/LL) drain to the heart by means of two left 
and two right pulmonary veins. The right cardinal vein becomes the superior caval vein (SCV) and the left 
cardinal vein gives rise to the coronary sinus (CS), both connecting to the sinus venosus part of the right 
atrium (RA).
 f,g. By incorporation of the CPV, initially, one right and one left CPV drain to the LA (f). After incorporation 
has completed, four separate pulmonary vein (PV) ostia can be identified on the inner side of the LA (g). 
The extracardiac part of the LCV regresses, becoming the so-called ligament of Marshall.
Development of the cardiac conduction system
In human embryos peristaltic contractions of the heart tube can be observed from 
the age of 3 weeks of development. After the heart has developed into its definitive 
segments, the myocardium differentiates either into working myocardium or in 
conducting myocardium, in which process neural crest cells as wells as EDPC’s play 
an inductive role31,46. According to the ballooning model47, the working myocardium 
of the atria and the ventricles differentiates from the outer curvatures of the looping 





































The conduction system can be divided into a central conduction system and a 
peripheral Purkinje network. The central conduction system has a sino-atrial and an 
atrioventricular component connected by the atrioventricular node. Studies using 
the antibody against HNK-1 and the transgenic CCS-LacZ mouse strain have described 
the developing cardiac conduction system in mice and men48-50 and show that there 
are two main transitional zones contributing to the central conduction system: 
the sinus venosus myocardium including the sino-atrial transition (or ring) and the 
primary fold (or ring) between the ventricular segments. The sino-atrial ring includes 
the left and right venous valves, the septum spurium, the myocardium surrounding 
the coronary sinus and the pulmonary veins and the interatrial Bachmann’s 
bundle51. Three internodal pathways, derived from the sino-atrial ring, connect the 
sino-atrial (SA) node with the atrioventricular (AV) node (Fig.3). The first pathway, 
represented by the fused venous valves or septum spurium, runs anterosuperiorly 
and connects to the transient anterior AV node, located to the anterior side of the 
right atrioventricular ring (rAVR), posterior to the aortic root. The second pathway 
runs laterally in the base of the right venous valve (the later crista terminalis of the 
right atrium) and connects together with the third pathway, running within the 
left venous valve through the base of the atrial septum, to the posterior AV node. 
Whether these anterior and posterior AV node anlagen fuse or whether the regular 
AV node solely consists of the embryonic posterior AV node is not completely clear6, 
but the functional AV node connects to the His bundle and the bundle branches. The 
atrioventricular conduction system is mainly derived from the primary ring, which 
encircles the aortic orifice and the right atrioventricular canal, thus forming the rAVR. 
(Fig.3). It was shown that the right ventricular moderator band is also continuous 
with the rAVR51. 
In the normal heart, only the SA node, the AV node, the His bundle and both 
bundle branches remain functional, while the internodal pathways, the embryonic 
conduction tissue surrounding the coronary sinus and the pulmonary veins and the 
rAVR disappear6. Therefore, discrimination between the developmental conduction 
system and the functional conduction system is essential since rhythm disturbances 
can be explained from the embryonic disposition of the conduction system as a 







































Figure 3. Embryonic parts of the conduction system derived from the sinoatrial ring (green) and the 
primary fold (yellow). The sinoatrial ring includes the right venous valve (RVV), the left venous valve (LVV), 
the septum spurium (SS), the myocardium surrounding the coronary sinus and the pulmonary veins (PV) 
and Bachmann’s bundle, being part of the left atrioventricular ring, running posterior to the aorta, in the 
roof of the left atrium (LA) to the right atrium (RA). The tissue of the primary fold or ring encircles the 
right atrioventricular canal (forming the right atrioventricular ring), and the aortic orifice. The definitive 
conduction system (depicted in red) consists of the sinoatrial node (SAN), the atrioventricular node (AVN), 
the common atrioventricular bundle (CB), the left bundle branch (LBB), and the right bundle branch (RBB). 
The parts of the conduction system depicted in yellow and green are supposed to disappear. It remains to 
be investigated if the anterior atrioventricular node (aAVN), which is connected to the SAN by the anterior 
internodal pathway running in the SS, becomes part of the regular AVN or solely features as an embryonic 
structure in addition to persisting in some cardiac malformations. Neural crest cells (NCC) can be found in 
proximity to structures of the cardiac conduction system, both as precursors of the autonomic neuronal 
network (depicted in dark blue) and after apoptosis as possible inducing cells (depicted in shaded blue). 
Aorta (Ao); epicardial derived cell (EPDC); left ventricle (LV); pulmonary trunk (PT); right ventricle (RV). 




































Although molecular biology, by the use of transgenic animal models, has attributed 
to the knowledge of normal and abnormal heart development, one has to realize 
that congenital heart malformations mostly are the result of highly complex cascades 
of gene interactions combined with epigenetic factors that cannot be deduced to 
isolated entities.
Aim of this thesis
In this thesis we describe normal and abnormal pulmonary vein development in 
human and mouse hearts, and focus on the histo(patho)logy of the pulmonary venous 
and left atrial dorsal wall, in order to elucidate the role of the posterior heart field in 
the formation and differentiation of the pulmonary venous vessel wall and its possible 
consequences for the onset of arrhythmias and susceptibility for pulmonary vein 
stenosis. Another aim of this thesis is that the understanding of normal pulmonary 
vein development will contribute to the understanding of the development of 
abnormal pulmonary venous connections and its clinical consequences.
Chapter outline
In Chapter 2 the normal development of the pulmonary veins and the left atrial dorsal 
wall is described in embryonic, neonatal and adult human hearts, with special focus 
on the histological consequences of the incorporation process of the pulmonary 
veins into the left atrium. The findings are discussed in relation to the pathogenesis 
of atrial arrhythmias.
In Chapter 3 the development and differentiation of the myocardium and vascular 
wall of the pulmonary veins, left atrial dorsal wall and atrial septum in wild type 
and podoplanin knockout mouse embryos of embryonic stages (E) 10.5-E18.5 is 
described, using 3-D reconstruction and immunohistochemistry. The role of the 







































In Chapter 4 the histopathological findings of the pulmonary venous and left atrial 
dorsal wall in human neonatal hearts with total anomalous pulmonary venous 
connection are attributed to abnormal posterior heart field contribution to the 
development of the venous pole of the heart and related to the findings in Chapter 
three. A clinical link to the origin of pulmonary vein stenosis is made.
Chapter 5 presents a clinical report on unilateral pulmonary vein stenosis with 
a contralateral pulmonary varix as an example of abnormal pulmonary vein 
development. A pulmonary varix is a dilated, tortuous pulmonary vein, usually 
resulting from obstructed pulmonary vein drainage. In this report, we try to link the 
clinical condition to an embryologic explanatory hypothesis which may or may not be 
combined with environmental factors (acquired disease).
Chapter 6 is an extended general discussion which reviews normal and abnormal 
pulmonary vein development, including the content of the chapters two to six. It 
outlines the importance of the posterior heart field in the etiology of congenital 
heart disease and emphasizes the need for improvement of knowledge on its (epi)





































 1.  Jongbloed MR, Mahtab EAF, Blom NA, Schalij MJ, Gittenberger-de Groot AC. Development of the 
cardiac conduction system and the possible relation to predilection sites of arrhythmogenesis. 
ScientificWorldJournal 2008;8:239-69.
 2.  Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le MA, Le 
MP, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the 
pulmonary veins. N Engl J Med 1998;33910:659-66.
 3.  Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, Torracca L, Benussi S, Alfieri O, 
Hong R, Lau W, Hirata K, Shikuma N, Hall B, Morady F. Atrio-esophageal fistula as a complication 
of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004;109:2724-6.
 4.  Mahtab EA, Vicente-Steijn R, Hahurij ND, Jongbloed MR, Wisse LJ, DeRuiter MC, Uhrin P, Zaujec J, 
Binder BR, Schalij MJ, Poelmann RE, Gittenberger-de Groot AC. Podoplanin deficient mice show a 
rhoa-related hypoplasia of the sinus venosus myocardium including the sinoatrial node. Dev Dyn 
2009;238:183-93.
 5.  Gittenberger-de Groot AC, Poelmann RE. Cardiac morphogenesis. In: Yagel S, Silverman NH, 
Gembruch U, eds. Fetal Cardiology. 2 ed. New York: Informa healthcare, 2009:9-17.
 6.  Gittenberger-de Groot AC, Jongbloed MRM, DeRuiter MC, Bartelings MM, Poelmann RE. 
Embryology of congenital heart disease. In: Crawford MH, DiMarco JP, Paulus WJ, eds. Cardiology. 
Third ed. Philadelphia: Mosby, 2009:1391-1402.
 7.  Levin M, Pagan S, Roberts DJ, Cooke J, Kuehn MR, Tabin CJ. Left/right patterning signals and the 
independent regulation of different aspects of situs in the chick embryo. Dev Biol 1997;189:57-67.
 8.  Olson EN, Srivastava D. Molecular pathways controlling heart development. Science 1996;272:671-
6.
 9.  Laverriere AC, Macniell C, Mueller C, Poelmann RE, Burch JBE, Evans T. GATA-4/5/6, a subfamily of 
three transcription factors transcribed in developing heart and gut. J Biol Chem 1994;269:23177-
84.
 10.  de la Cruz M, Sanchez-Gomez C, Palomino MA. The primitive cardiac regions in the straight tube 
heart (Stage 9-) and their anatomical expression in the mature heart: an experimental study in the 
chick heart. J Anat 1989;165:121-31.
 11.  Moreno-Rodriguez RA, Krug EL, Reyes L, Villavicencio L, Mjaatvedt CH, Markwald RR. Bidirectional 
fusion of the heart-forming fields in the developing chick embryo. Dev Dyn 2006;235:191-202.
 12.  Kelly RG. Molecular inroads into the anterior heart field. Trends Cardiovasc Med 2005;15:51-6.
 13.  Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. Isl1 identifies a cardiac progenitor population 
that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 
2003;5:877-89.
 14.  Martinsen BJ, Frasier AJ, Baker CV, Lohr JL. Cardiac neural crest ablation alters Id2 gene expression 
in the developing heart. Dev Biol 2004;272:176-90.
 15.  Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf10-
expressing cells in pharyngeal mesoderm. Dev Cell 2001;1:435-40.
 16.  Xu H, Morishima M, Wylie JN, Schwartz RJ, Bruneau BG, Lindsay EA, Baldini A. Tbx1 has a dual role 
in the morphogenesis of the cardiac outflow tract. Development 2004;131:3217-27.
 17.  Mjaatvedt CH, Nakaoka T, Moreno-Rodriguez R, Norris RA, Kern MJ, Eisenberg CA, Turner D, 
Markwald RR. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol 
2001;238:97-109.
 18.  Waldo K, Kumiski DH, Wallis KT, Stadt HA, Hutson MR, Platt DH, Kirby ML. Conotruncal myocardium 
arises from a secondary heart field. Development 2001;128:3179-88.






































 20.  Molin DGM, Roest PA, Nordstrand H, Wisse LJ, Poelmann RE, Eriksson UJ, Gittenberger-de Groot 
AC. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies 
in the offspring of diabetic rats. Birth Defects Res A Clin Mol Teratol 2004;70:927-38.
 21.  Roest PAM, van Iperen L, Vis L, Wisse LJ, Poelmann RE, Steegers-Theunissen RGM, Molin DGM, 
Eriksson UJ, Gittenberger-de Groot AC. Exposure of neural crest cells to elevated glucose leads to 
congenital heart defects, an effect that can be prevented by N-acetylcysteine. Birth Defects Res A 
Clin Mol Teratol 2007;79:231-5.
 22.  Boot MJ, Steegers-Theunissen RP, Poelmann RE, van Iperen L, Gittenberger-de Groot AC. 
Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res 
2004;64:365-73.
 23.  Hogers B, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE. Unilateral vitelline vein 
ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo. Circ Res 
1997;80:473-81.
 24.  Mommersteeg MT, Brown NA, Prall OW, de Gier-de VC, Harvey RP, Moorman AF, Christoffels VM. 
Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ 
Res 2007;101:902-9.
 25.  Gittenberger-de Groot AC, Mahtab EAF, Hahurij ND, Wisse LJ, DeRuiter MC, Wijffels MCEF, 
Poelmann RE. Nkx2.5 negative myocardium of the posterior heart field and its correlation with 
podoplanin expression in cells from the developing cardiac pacemaking and conduction system. 
Anat Rec 2007;290:115-22.
 26.  Christoffels VM, Mommersteeg MT, Trowe MO, Prall OW, Gier-de Vries C, Soufan AT, Bussen M, 
Schuster-Gossler K, Harvey RP, Moorman AF, Kispert A. Formation of the venous pole of the heart 
from an Nkx2-5-negative precursor population requires Tbx18. Circ Res 2006;98:1555-63.
 27.  Blaschke RJ, Hahurij ND, Kuijper S, Just S, Wisse LJ, Deissler K, Maxelon T, Anastassiadis K, Spitzer 
J, Hardt SE, Schöler H, Feitsma H, Rottbauer W, Blum M, Meijlink F, Rappold GA, Gittenberger-de 
Groot AC. Targeted mutation reveals essential functions of the homeodomain transcription factor 
Shox2 in sinoatrial and pacemaking development. Circulation 2007;115:1830-8.
 28.  Mahtab EAF, Wijffels MCEF, van den Akker NMS, Hahurij ND, Lie-Venema H, Wisse LJ, DeRuiter 
MC, Uhrin P, Zaujec J, Binder BR, Schalij M.J., Poelmann RE, Gittenberger-de Groot AC. Cardiac 
malformations and myocardial abnormalities in podoplanin knockout mouse embryos: correlation 
with abnormal epicardial development. Dev Dyn 2008;237:847-57.
 29.  Poelmann RE, Gittenberger-de Groot AC. A subpopulation of apoptosis-prone cardiac neural crest 
cells targets to the venous pole: multiple functions in heart development? Dev Biol 1999;207:271-
86.
 30.  Verberne ME, Gittenberger-de Groot AC, VanIperen L, Poelmann RE. Distribution of different 
regions of cardiac neural crest in the extrinsic and the intrinsic cardiac nervous system. Dev Dyn 
2000;217:191-204.
 31.  Poelmann RE, Jongbloed MR, Molin DGM, Fekkes ML, Wang Z, Fishman GI, Doetschman T, Azhar 
M, Gittenberger-de Groot AC. The neural crest is contiguous with the cardiac conduction system 
in the mouse embryo: a role in induction? Anat Embryol 2004;208:389-93.
 32.  Viragh S, Gittenberger-de Groot AC, Poelmann RE, Kalman F. Early development of quail heart 
epicardium and associated vascular and glandular structures. Anat Embryol 1993;188:381-93.
 33.  Kruithof BP, van Wijk B, Somi S, Kruithof-de Julio M, Perez Pomares JM, Weesie F, Wessels A, 
Moorman AF, van den Hoff MJ. BMP and FGF regulate the differentiation of multipotential 
pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol 2006;295:507-22.
 34.  Männer J, Perez-Pomares JM, Macias D, Munoz-Chapuli R. The origin, formation and developmental 
significance of the epicardium: a review. Cells Tissues Organs 2001;169:89-103.
 35.  Vrancken Peeters M-PFM, Mentink MMT, Poelmann RE, Gittenberger-de Groot AC. Cytokeratins 
as a marker for epicardial formation in the quail embryo. Anat Embryol 1995;191:503-8.
 36.  Gittenberger-de Groot AC, Vrancken Peeters M-PFM, Mentink MMT, Gourdie RG, Poelmann 
RE. Epicardium-derived cells contribute a novel population to the myocardial wall and the 




































 37.  Perez-Pomares JM, Phelps A, Munoz-Chapuli R, Wessels A. The contribution of the proepicardium 
to avian cardiovascular development. Int J Dev Biol 2001;45(S1):S155-6.
 38.  Winter EM, Gittenberger-de Groot AC. Cardiovascular development: towards biomedical 
applicability : Epicardium-derived cells in cardiogenesis and cardiac regeneration. Cell Mol Life Sci 
2007;64:692-703.
 39.  Lie-Venema H, van den Akker NMS, Bax NAM, Winter EM, Maas S, Kekarainen T, Hoeben RC, 
DeRuiter MC, Poelmann RE, Gittenberger-de Groot AC. Origin, fate, and function of epicardium-
derived cells (EPCDs) in normal and abnormal cardiac development. ScientificWorldJournal 
2007;7:1777-98.
 40.  Eralp I, Lie-Venema H, DeRuiter MC, Van Den Akker NM, Bogers AJ, Mentink MM, Poelmann RE, 
Gittenberger-de Groot AC. Coronary artery and orifice development is associated with proper 
timing of epicardial outgrowth and correlated Fas ligand associated apoptosis patterns. Circ Res 
2005;96:526-34.
 41.  Lie-Venema H, Gittenberger-de Groot AC, van Empel LJP, Boot MJ, Kerkdijk H, de Kant E, DeRuiter 
MC. Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial 
development in chicken embryos. Circ Res 2003;92:749-56.
 42.  Eralp I, Lie-Venema H, Bax NAM, Wijffels MC, Van der Laarse A, DeRuiter MC, Bogers AJ, Van Den 
Akker NM, Gourdie RG, Schalij MJ, Poelmann RE, Gittenberger-de Groot AC. Epicardium-derived 
cells are important for correct development of the Purkinje fibers in the avian heart. Anat Rec 
2006;288:1272-80.
 43.  Moore KL, Persaud TVN. The respiratory system. In: Saunders WB, ed. The Developing human. 
Clinically oriented embryology. 7th ed. Philadelphia: 2003:245-53.
 44.  DeRuiter MC, Poelmann RE, Mentink MMT, van Iperen L, Gittenberger-de Groot AC. Early 
formation of the vascular system in quail embryos. Anat Rec 1993;235:261-74.
 45.  Rammos S, Gittenberger-de Groot AC, Oppenheimer-Dekker A. The abnormal pulmonary venous 
connexion: a developmental approach. Int J Cardiol 1990;29:285-95.
 46.  Gittenberger-de Groot AC, Blom NM, Aoyama N, Sucov H, Wenink AC, Poelmann RE. The role of 
neural crest and epicardium-derived cells in conduction system formation. Novartis Found Symp 
2003;250:125-34.
 47.  Christoffels VM, Habets PE, Franco D, Campione M, de Jong F, Lamers WH, Bao ZZ, Palmer S, Biben 
C, Harvey RP, Moorman AF. Chamber formation and morphogenesis in the developing mammalian 
heart. Dev Biol 2000;223:266-78.
 48.  Blom NA, Gittenberger-de Groot AC, DeRuiter MC, Poelmann RE, Mentink MM, Ottenkamp J. 
Development of the cardiac conduction tissue in human embryos using HNK-1 antigen expression: 
possible relevance for understanding of abnormal atrial automaticity. Circulation 1999;99:800-6.
 49.  Rentschler S, Vaidya DM, Tamaddon H, Degenhardt K, Sassoon D, Morley GE, Jalife J, Fishman 
GI. Visualization and functional characterization of the developing murine cardiac conduction 
system. Development 2001;128:1785-92.
 50.  Wenink ACG, Symersky P, Ikeda T, DeRuiter MC, Poelmann RE, Gittenberger-de Groot AC. HNK-1 
expression patterns in the embryonic rat heart distinguish between sinuatrial tissues and atrial 
myocardium. Anat Embryol 2000;201:39-50.
 51.  Jongbloed MRM, Schalij MJ, Poelmann RE, Blom NA, Fekkes ML, Wang Z, Fishman GI, Gittenberger-
de Groot AC. Embryonic conduction tissue: a spatial correlation with adult arrhythmogenic areas? 





































Yvonne L. Douglas1,3*, Monique R.M. Jongbloed2,3*, Adriana C. Gittenberger-de Groot3, 
Dorothea Evers3, Robert A.E. Dion4, Pieter Voigt4, Margot M. Bartelings3, Martin J. Schalij2, 
Tjark Ebels¹, Marco C. DeRuiter3.
*Both authors contributed equally
Depts of 1Cardio-thoracic Surgery, University Medical Center Groningen, University of Groningen, 
2Cardiology, 3Anatomy and Embryology, 4Cardio-thoracic Surgery, Leiden University Medical Center, 
Leiden, The Netherlands.
2
Histology of Vascular-Myocardial Wall 
of Left Atrial Body after Pulmonary 
Venous Incorporation
Modified after





































During embryonic development the common pulmonary vein (PV) becomes 
incorporated into the left atrium (LA), giving rise to separate PV ostia. We 
describe the consequences of this incorporation process for the histology of 
the LA and the possible clinical implications. The histology of the LA wall in 
relation to PV incorporation was studied immunohistochemically in 16 human 
embryos and fetuses, one neonate and 5 adults. The PV wall, surrounded by 
extrapericardially differentiated myocardial cells, incorporated into the LA 
body. After incorporation, the composition of PVs and smooth-walled LA 
body wall was histologically identical. The LA appendage however, consisted 
of an endocardial and myocardial layer without a vessel wall component. In 2 
adults, the myocardium in the LA posterior wall was absent. At the transition 
of the LA body and the LA appendage, a smooth-walled myocardial zone 
lacking the venous wall was observed. This zone was histologically identical 
to the sinus venarum of the right atrium. In conclusion, the LA body arises 
by incorporation and growth of the PVs, presenting with a histologically 
identical structure of vessel wall covered by extrapericardially differentiated 
myocardium of the PVs. Discontinuity of myocardium may be the substrate 
for arrhythmias, whereas absence of myocardium in some individuals makes 
this area potentially vulnerable to damage inflicted by ablation strategies. A 
borderzone between the LA body and the LA appendage is hypothesized to be 







































During development, the common PV becomes myocardialized whereafter it 
is incorporated into the posterior LA wall giving rise to separate PV orifices1. The 
degree of incorporation is variable between individuals and only about 75% to 
80% of individuals possess 4 discrete PV orifices2,3. Though the development and 
incorporation of the PVs has been studied and several histological studies of the LA 
and the PVs have been performed, until now, there are no extensive reports that 
emphasize the histological result of PV incorporation in the LA in subsequent stages 
in the human. It seems logical to expect characteristic venous wall tissue, consisting 
of an intima, media with elastin and smooth muscle cells (SMCs) in the LA after the 
incorporation process, but no histological veno-atrial border has been described in 
the literature. In the cardiology cathlab this atriovenous border and the structure of 
the LA and the PV have gained interest in recent years, in relation to the treatment 
of atrial fibrillation originating from the PV4. Ablation strategies, aimed at electrical 
isolation of the PV from the LA are often targeted at the left atrial tissue just outside 
the atriovenous junction to avoid the occurrence of PV stenosis by damaging the 
vulnerable PV vessel wall5. The present study investigates the histological outcome 
of the incorporation process of the PVs in the LA during subsequent stages of 
development.
Methods 
Normal hearts of 16 human embryos and fetuses, 1 neonate and 5 adults were studied. 
The embryos and fetuses, obtained by legal or spontaneous abortion, ranged from 7 
to 22 weeks (crown-rump lengths from 19 to 170 mm). The studies were approved 
by the local medical-ethical committee. The neonate had died during delivery as a 
result of asphyxia. Adult hearts were obtained from human bodies used in anatomy 
teaching lessons. The cause of death was unknown due to privacy regulations. 
Preservation of the bodies was performed by injection of embalming fluid in the 




































phenol, K2SO4, Na2SO4, NaHCO3 and Na2SO3. The fetal and neonatal specimens were 
fixed in a 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.2). 
Samples/sectioning of material. Embryonic hearts were embedded in paraffin and 
serially sectioned transversely (5-10 mm). From the neonatal and adult hearts, cross-
sectional samples were taken from all PVs, the posterior and anterior LA wall, and the 
LA appendage. Samples taken from the posterior and anterior right atrial wall and 
the right atrial appendage served as reference. Samples were embedded in paraffin 
and sectioned (5 μm) using a Leica microtome. Sections were mounted onto slides 
using chicken albumine dissolved in glycerine (1:1) and dried at 37º C for at least 24 
hours.
Staining. Standard histological stainings were performed with Haematoxilin-Eosin 
(HE), Elastic Van Gieson (EvG) or elastic Resorcin-Fuchsin (RF) to detect elastic 
filaments, and Sirius Red to demonstrate collagen fibers 6. Furthermore, sections were 
stained immunohistochemically with the pan-muscle actin antibody HHF35 (1:500, 
Dako, M0635), to study myocardial structure, 1A4 (1:3000, Sigma Aldrich, Product 
No. A2547) against alpha-smooth muscle (SM) actin, and an antibody against atrial 
myosin light chain (MLC2a, 1:2000, a generous gift of Steve Kubalak), specific for 
atrial myocardium. Staining procedures were performed as described previously7,8.
Results
Embryonic stage: Seven to 7.5 weeks of gestation, crown-rump length 19 to 24 
mm: Proximal to the heart, 4 PVs drained via a common PV into the smooth-walled 
segment of the LA (Fig.1a), also called the LA body, that could already be distinguished 
from the trabeculated LA appendage. The wall of both the intra- and extrapulmonary 
parts of the veins consisted of 1-3 layers of alpha-SM actin expressing SMCs around 
the endothelium (Fig.1b,e). The extrapulmonary part of the PVs being continuous 
with the dorsal wall of the LA were encircled by an additional layer of MLC-positive 
myocardial cells (Fig.1c,d). In the wall of the intrapulmonary part of the veins 
myocardial cells were absent (Fig.1f). The LA wall does not express smooth muscle 







































Sections of a 54 days old human embryo stained with HHF35 for muscle actins (a; actin), alpha-smooth 
muscle actin (b,e; SM actin), atrial myosin light chain (c,d,f; MLC), showing the differentiation of the 
pulmonary veins (PVs) and their entrance in the left atrial body (LAB). a. Four PVs (arrows) drain via one 
common pulmonary vein (CPV) into the LAB. The wall of both intra- and extrapulmonary PVs consists of 1-3 
layers of smooth muscle cells (SMC) (b), while an additional layer of actin and MLC positive myocardium 
(Myo) only encircles the extrapulmonary part of the vessel wall (c-f). Consecutive sections in c, d and e 
demonstrate that part of the MLC-positive myocardial cells surrounding the smooth muscle cells of the 
PVs (Myo) are also 1A4-positive, which is related to early differentiating myocardial cells21. Beneath these 
myocardial cells a real SMC layer develops (e; arrow head). Bronchus (B), Intra/extrapulmonary borderline 
(----), lung (Lu), left venous valve (LVV), lung hilum (LH), mitral valve (MV), pericardial cavity (P), right 




































Fetal stages: Ten to 22 weeks’ gestation, crown-rump length 42 to 170 mm: As 
incorporation of the common PV had progressed, in all but 2 fetuses there were 2 
separate right pulmonary venous orifices, while 2 left PVs drained via one common 
left PV into the LA. At 16 weeks, in 2 fetuses (out of 5) four separate PV ostia were 
observed. From the lung hilum to the heart, the PVs were completely covered 
by myocardium. Subendothelially, the wall of the PVs consisted of 1-3 layers of 
SMCs embedded within a collagenous matrix (Fig.2a-c). This layer extended from 
the intrapulmonary veins to the smooth-walled LA body (Fig.2d,e). A thin layer of 
collagen was also found in the LA appendage, atrial septum and in the complete right 
atrium, but no SMCs were observed (Fig.2f-k). The myocardial layer around the PVs 
had thickened as well as the subendothelial collagenous vessel wall with SMCs in the 
PVs and the LA body. The presence of vascular SMCs in the heart was restricted to 
the LA body. At 21 weeks, the first indication of elastic fiber formation was observed 
within this layer (Fig.2l).
Figure 2a-l
Sections of a 15.5 week old human embryo. Boxes in Fig.a indicate the position of the enlargements in 
b-k. RF-sirius red stained sections in c, e, g, i, k and l are adjacent sections of Fig.a, b, d, f, h and j, that are 
stained for alpha-SM actin. Collagen fibers are red and elastic fibers are black in the RF stained sections.
a-c. Smooth muscle cells (SMCs) have differentiated within the subendothelial collagenous matrix of the 
pulmonary vessel wall (VW). d,e. This differentiating vessel wall extends into the smooth-walled left atrial 
body (LAB). Although the left atrial appendage (LAA), the septum primum (S1), and the right atrial body 
(RAB) have a thin subendothelial collagen matrix (g, i, k) no SMCs are found (f, h, j). l. At 21 weeks elastin is 
deposited (arrows) in the differentiating venous vessel wall in the LAB. Aorta (Ao), epicardium (E), external 
borderline (------) of the VW, left ventricle (LV), lumen (L), myocardium (Myo). Scale bar = 500 mm in a; 100 









































































Neonatal stage: Pulmonary veins and left atrial body: As in previous stages there were 
2 separate right PV ostia and one common left PV ostium. At the transition of the PV 
ostia and LA body no histological veno-atrial demarcation was found (Fig.3a,b). In both 
the PVs and the LA body the following layers could be distinguished: an inner venous 
vessel wall with an endothelium, several medial layers of SMCs with longitudinally 
oriented elastic fibers, and an adventitial layer with randomly distributed elastic 
fibers with fibroblasts and vasa vasorum. These vessel wall structures were covered 
by a myocardial layer and an epicardium on the outside (Fig.3a-d).
Left atrial appendage: In the trabeculated LA appendage the inner surface consisted 
of an endocardium with a thin subendocardial sheet consisting of well-organized 
collagen and elastic fibers, but without well-organized layers of alpha-SM actin 
positive cells. Only a few scattered actin positive cells were found. Characteristic 
vessel wall layers as seen in the body of the atrium, were lacking (Fig.3e,f). At the 
outer side, a thick layer of myocardium covered by an epicardium was present.
Right atrium: The right atrial body or sinus venarum consisted of smooth-walled 
myocardium. The inner side of the wall near the systemic veins consisted of one 
layer of SMCs. This layer did not represent a proper tunica media as seen in the 
systemic veins which had a well organized vessel wall with five layers of SMCs. At 
the junction of the terminal crest with the right atrial body, this smooth muscle layer 
disappeared (Fig.3g). Within the trabeculated right atrial appendage, only scattered 
subendocardial SMCs were observed (Fig.3h).
Figure 3a-h
Sections of various segments of a human neonatal heart. a-d At the transition of the PV and LA body 
no histological veno-atrial demarcation was found. The wall consisted of an endothelium/endocardium, 
a medial layer (M) with smooth muscle cells (SMCs) and elastic fibers, an adventitial layer (A) with 
fibroblasts and elastic fibers, a sheet of myocardium (Myo) and an outer epicardium (E). e,f In the left 
atrial appendage (LAA) no organized vessel wall was present. Only a subendothelial layer of elastin (e) and 
isolated SMCs (arrows in f) was present. In the right atrium only one layer of SMCs, not characteristic for a 
tunica media, could be detected in the right atrial body (arrow heads in g) near the entrance of the caval 
veins. The histology of the right atrial appendage (RAA) is comparable with the LAA with only isolated 
SMCs (arrows; h). Terminal crest (CT), Lumen (L), pericardial cavity (P). Scale bar = 500 mm in a,b,g; 100 
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Adult stage: Pulmonary veins and left atrial body: The PVs of 4 adult hearts had 
discrete PV orifices. In one heart a common left PV orifice was still present. In 2 hearts, 




































the wall of the LA body consisted of a non-trabeculated myocardial layer. Around the 
outside of the PVs this myocardium formed a circular or spirally arranged muscular 
sleeve. The sleeves tended to be thicker and more complete near the junction with 
the posterior LA body, but tapered more distally. In the PVs, a characteristic vessel 
wall was found consisting of an intimal layer and a medial layer with SMCs (Fig.4a). In 
the wall of the entire LA body, in addition to the outer myocardial layer, a prominent 
vessel wall layer being continuous with the PV vessel wall was present (Fig.4b). 
In between the media and myocardium an adventitial layer with fibroblasts (not 
expressing SM actin) was found (Fig.4a,b). In contrast to the neonatal stage, intimal 
thickening was observed in the PVs and the LA body, which was most profound in 
the PVs (Fig.4a,b). At the entry of the PVs into the LA, no histological demarcation 
was found. Interestingly, at the junction of the LA body with the LA appendage, a 
borderzone with distinctive tissue was identified (Fig.4c-e). The inner surface of 
this area lacked trabeculation. In contrast to the remaining part of the LA body and 
the PVs, the characteristic tunica media was lacking in this borderzone (Fig.4d,e). 
Another finding was that the myocardium at the transition of the LA body and the 
trabeculated LA appendage was either very thin or absent (Fig.4c,e). Moreover, in 2 
of the adult hearts examined, the myocardium covering the LA body in between the 
confluence of the 4 PVs was discontinuous thus allowing the epicardium to line the 
vessel wall of the PVs (Fig.4g,h). These areas of discontinuous myocardium were only 
several millimeters wide. It should, however, be noted that in these areas (partly) 
isolated bundles of myocytes were observed.
Figure 4a-h
Adult stage sections stained for alpha-smooth muscle actin (a,b,d,f; SM actin), Elastic Van Gieson (c,e; 
EvG) and Resorcin-Fuchsin (g; RF). (h) is a macroscopical picture of the area in between the confluence of 
the PVs where discontinuous myocardium is found as shown in (g). Boxes in (c) indicate the position of the 
enlargements in (d,e). In EvG stained sections collagen fibers are purple and elastic fibers are black, in RF 
stained sections collagen fibers are red and elastic fibers are black.
a,b. In the pulmonary veins (PV) as well as in the left atrial body (LAB) an identical and characteristic vessel 
wall is found consisting of an intimal layer (I), a medial layer (M; double arrow) with smooth muscle cells 
(SMCs) and elastic lamellae, and an adventitial layer (A) in between the media and myocardium (Myo). In 
contrast to the neonatal stage, a profound intimal thickening is observed, most profound in the PVs. At the 
junction of the LAB with the left atrial appendage (LAA) a borderzone with distinctive tissue is identified 
(c,d; arrow). The inner surface of this area lacks trabeculation and vessel wall tissue (d). The myocardium 
at the transition between LAB and LAA is very thin or absent, facing the epicardium (c,e: asterisk). f. On 
the inner surface of the LAA occasional SMCs are found (arrows) but a vessel wall component is lacking.
g,h. In between the confluence of the four PVs, in two adults, the myocardium (Myo) is discontinuous or 









































































Atrial appendages: The wall of the trabeculated LA appendage differed from the PVs 
and LA body in that it did not contain a vessel wall component. The inner surface 
consisted of a thin subendocardial collagenous layer with some elastic fibers and an 
occasional SMC (Fig.4f). The histology of the LA appendage was similar to that of the 
right atrial appendage (Fig.5a,b).
Right atrial body: The non-trabeculated sinus venarum of the right atrium consisted 
at the inside of a thin subendocardial collagenous layer covered by myocardium. No 
characteristics of vessel wall structures were present at this site (Fig.5c,d). 
Figure 5a-d
Adult stage sections stained with HHF35 for muscle actins (a; actin), alpha-smooth muscle actin (b,d-f; SM 
actin) and Elastic Van Gieson (c; EvG). (b) and (d) are adjacent sections of (a) and (c). 
a,b. At the transition of the smooth-walled right atrial body (RAB) to the trabeculated right atrial 
appendage (RAA), the myocardial layer (Myo) is very thin (a; arrow) comparable to the left side. In the 
RAA, vessel wall tissue is absent (b) which is comparable to the left atrial appendage. c,d. The right atrial 
body (RAB) consists at the inner side of a thin subendocardial layer (c; arrow), covered by myocardium 
(Myo). No characteristics of vessel wall tissue were present at this site (d). Terminal crest (CT), lumen (L). 







































In this study, the histological outcome of the incorporation of the PVs into the LA was 
described in subsequent developmental stages. Our study demonstrates that, based 
on histological criteria, 3 different compartments can be distinguished in the LA 
(schematically demonstrated in Fig.6): the smooth-walled LA body with vessel wall 
tissue (i.e. incorporated PV tissue); the trabeculated LA appendage, without vessel 
wall tissue; and a transitional zone in between the LA appendage and the LA body, 
which is smooth-walled and lacks vessel wall tissue. The right atrial appendage, the 
body of the right atrium and the atrial septum are not lined by vessel wall tissue. The 
borderzone between the LA appendage and the LA body histologically resembles the 
smooth-walled sinus venarum (body) of the right atrium.
The origin of the PVs is an issue of controversy. Based on findings using the marker 
HNK-1, several authors have described that the myocardium surrounding the 
primitive PV in the LA is continuous with the sinus venosus in the right atrium9-11. 
However, other authors have disputed this relation12. These discrepancies depend 
largely on different application of definitions (especially how to define the sinu-atrial 
transition and the sinus venosus), and on different interpretation of possibly similar 
observations. Regardless of these differences, most authors seem to agree that the 
myocardium surrounding the primitive PV possesses different characteristics and can 
be differentiated from the working myocardium of the LA appendage. The aim of 
the current study was not to provide the answer for the origin of the primitive PV. 
However, based on the observation of a zone of myocardium at the transition of 
the LA appendage with the LA body that histologically resembles the sinus venosus 
in the right atrium, we hypothesize that during incorporation of the PV and the 
surrounding myocardium into the LA, the contribution of vessel wall to the body of 
the LA increases, which may reduce the area of sinus venosus myocardium to a small 
zone encircling the entrance to the LA appendage. An interesting finding was the 
very thin or even absent myocardium at this junction zone between the LA body and 
the LA appendage; within this zone slow conduction or conduction block may occur 





































a. Schematic depiction of the outer side of the atrial chambers with the pulmonary veins (PV) and systemic 
veins. The left atrial body (LAB) and right atrial body (RAB) are covered by myocardium with a smooth-
walled inner aspect (blue), which stretches out over the extracardiac segments of the PV and over a small 
peripheral part of the systemic veins (blue area above and below dotted line). The left atrial appendage 
(LAA) and right atrial appendage (RAA) consist of trabeculated myocardium (brown). A zone of smooth-
walled myocardium that lacks characteristics of vessel wall tissue is found at the junction of the LAB to the 
LAA (blue between dotted lines). b. Schematic depiction of the tissue types found in the left and right atria 
seen from the inside of the atria. Vessel wall tissue (red), myocardial tissue with a smooth-walled inner 
aspect (blue), primary atrial segment tissue (brown), transitional zone (asterisk) which is smooth-walled, 
lacking vessel wall tissue (hypothesized to be left-sided sinus venosus tissue). Coronary sinus (SC), inferior 
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At early stages, the wall of the PVs consisted of a mixture of extrapericardially 
differentiated myocardial cells and SMCs. These SMCs proliferated and differentiated 
into an inner venous vessel wall. In the neonate and the adult, due to the incorporation 
process of the PVs, vessel wall tissue and extrapericardially differentiated myocardium 
were not only present in the PVs, but also in the LA body. It is currently unclear 
whether the outer circular or spirally arranged myocardial sleeves are formed due to 
extracardial mesenchymal triggers as is strongly supported by studies of Kruithof et 
al.14,15, or are a direct continuation of the LA myocardium as supposed by Millino in the 
mouse16. Our study demonstrates that the myocardium and venous wall differentiate 
simultaneously, but does not support either a cardiac or an extracardiac origin.
In the adult PVs and the LA body, beneath the endothelium/endocardium a prominent 
fibroelastic subendothelial layer was observed, which extended to a lesser extent in 
the right and left appendages and the atrial septum. Interestingly, in the neonatal 
stage, only a very thin subendothelial layer was observed, raising the possibility of 
an aging reaction to different stimuli e.g. continuous shear stress. In congenital heart 
diseases causing persistent and increased wall tension on the ventricles e.g. aortic 
stenosis or atresia and hypoplastic left heart, a comparable intimal thickening, so-
called fibroelastosis, can be found17. However, as all our adult hearts showed this 
intimal thickening, it is debatable whether these findings represent a true form of 
fibroelastosis or are part of normal aging. Reactive intimal thickening in the PVs, 
leading to PV stenosis, can be seen after ablative therapy for arrhythmias, which 
suggests that the intimal layer is not only susceptible to internal but also to external 
stimuli18. Especially in this context, the results of this study can be of importance 
since it demonstrates that the LA body contains areas of discontinuous myocardium 
and areas without myocardium, e.g. in between the PV orifices, that might be the 
electrophysiological substrate of arrhythmias13. An increased susceptibility for 
arrhythmias may be explained by a difference in the composition of the extracellular 
matrix, the cellular junctions or the phenotype of these extrapericardially 
differentiated myocardial cells with regard to the intrapericardially differentiated 
myocardial cells of the sinus venosus and the atrial segment. These arrhythmias are 
amenable to catheter ablation but one must be alert that the vessel wall can be 




































important when performing ablation at the LA dorsal wall, that is in close contact to 
the esophagus. Recent studies have emphasized the risk of atrio-esophageal fistula 
due to the application of radiofrequency current at this site19,20. Lower dosage of 
radiofrequency current is therefore recommended when ablating in this area.
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Pulmonary Vein, Dorsal Atrial Wall 
and Atrial Septum Abnormalities 
in Podoplanin Knockout Mice with 








































The developing sinus venosus myocardium, derived from the posterior heart 
field, contributes to the atrial septum, the posterior atrial wall, the sino-
atrial node and myocardium lining the pulmonary and cardinal veins, all 
expressing podoplanin, a coelomic and myocardial marker. We compared 
development and differentiation of the myocardium and vascular wall of the 
pulmonary veins, left atrial dorsal wall and atrial septum in wild type with 
podoplanin knockout mouse embryos (E10.5-E18.5) by 3-D reconstruction 
and immunohistochemistry. Expression of Nkx2.5 in the pulmonary venous 
myocardium changes from mosaic to positive during development pointing 
out a high proliferative rate compared to Nkx2.5 negative myocardium of the 
sino-atrial node and cardinal veins. In mutants, myocardium of the pulmonary 
veins, dorsal atrial wall and atrial septum was hypoplastic. The atrial septum 
and right sided wall of the pulmonary vein almost lacked interposed 
mesenchyme. Extension of smooth muscle cells into the left atrial body was 
diminished. We conclude that myocardium of the pulmonary veins, dorsal 
atrial wall and atrial septum as well as the smooth muscle cells are derived 







































The developmental origin and molecular mechanisms controlling the formation of 
the myocardium of the pulmonary veins (PV) and the smooth muscle cells (SMCs) 
of the PV media are a matter of debate. The PV myocardial sleeve develops by 
either migration of myocardial cells from the left atrium (LA)1 or by recruitment of 
extracardiac mesenchymal cells which differentiate into myocardial cells2. Based 
on expression patterns of Nkx2.5, Islet1 and Pitx2c the LA and PV myocardium was 
suggested to be formed by the addition of myocardial cells from the second heart 
field at the venous pole3.
The second heart field, part of the splanchnic mesoderm, is involved in the addition 
of (myocardial) cells to the primary heart tube at both the arterial (the secondary 
and anterior heart field) and the venous pole (the posterior heart field)4. Islet1, a 
marker of undifferentiated cardiac progenitor cells, is expressed throughout the 
second heart field5. Myocardial cells can differentiate from second heart field derived 
mesenchymal cells, and SMCs may also differentiate from mesenchyme6.
The transmembrane glycoprotein podoplanin, a coelomic and myocardial marker 
expressed in the posterior heart field7, has gained interest for its role in epithelial-
to-mesenchymal transformation (EMT) and in formation of the myocardium and 
coronary SMCs at the venous pole of the heart8. It is found in the proepicardial 
organ, epicardium, sinus venosus myocardium including the sino-atrial node, the PVs 
and cardinal veins, the dorsal atrial wall and the base of the atrial septum extending 
into the developing atrial and ventricular cardiac conduction system. Podoplanin 
promotes EMT by binding ezrin, radixin, moesin (ERM) proteins that activate RhoA, 
and by downregulation of the cell-to-cell adhesion molecule E-cadherin9. Lack of 
podoplanin leads to altered EMT and e.g., to abnormal formation of sinus venosus 
myocardium and decreased numbers of SMCs of the coronary artery media8. In extra 
cardiac tissues podoplanin functions as a possible signalling molecule and is involved 
in the development of osteoblasts10 intestinal and alveolar epithelium11 podocytes 
and mesothelium of the visceral peritoneum12 and lymphatic endothelium13. During 
cardiac development, podoplanin is expressed specifically in the second heart field 




































Our previous study in humans14 demonstrated that during incorporation of the PVs 
in the LA body, the inner lining of the LA body presents vessel wall tissue. The outer 
layer of the LA is formed by myocardium covered by epicardium. The origin of the 
SMCs of the LA dorsal wall is still a topic of discussion. 
In the present study, we have compared the morphology and development of the 
wall of the PVs, LA dorsal wall and atrial septum between wild type and podoplanin 
knockout mouse embryos of embryonic stages (E) 10.5-18.5. We hypothesize that 
the posterior heart field is involved in the formation and differentiation of both 
myocardial cells and SMCs of the PVs and LA dorsal wall regulated by podoplanin.
Material and methods
Generation of the embryonic and neonatal mice 
This study was performed at the department of Anatomy & Embryology of the Leiden 
University Medical Center and was approved by the Animal Research Committee. 
Podoplanin knockout mice were generated by homologous recombination in 
embryonic stem cells from the 129S/v mouse line as reported previously8.
General description 
We investigated the morphology and development of the sinus venosus region 
of the heart, especially the PVs, LA dorsal wall and atrial septum in 32 wild type 
mouse embryos of E10.5 (n=4), E11.5 (n=3), E12.5 (n=4), E13.5 (n=5), E14.5 (n=4), 
E15.5 (n=3), E16.5 (n=3), E17.5 (n=3) and E18.5 (n=3), and compared these with 28 
podoplanin knockout mouse embryos of E10.5 (n=4), E11.5 (n=5), E12.5 (n=5), E13.5 
(n=3), E14.5 (n=4), E15.5 (n=4) and E18.5 (n=3). 
Immunohistochemistry 
Immunohistochemistry was performed with antibodies against alpha-smooth-muscle 
actin (1A4, 1:2000, Sigma Aldrich, Product No.A2547, USA) to detect differentiated 
SMCs and developing myocardium, atrial myosin light chain 2 (MLC2a, 1/6000, kindly 
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transcription factor related locus 5 (Nkx2.5, 1/4000, Santa Cruz Biotechnology, Inc., 
CA, USA, SC-8697) as an early marker of undifferentiated cardiac progenitor cells, 
and podoplanin (clone 8.1.1., 1/500, Hybridomabank, Iowa, USA) as a marker of 
the posterior heart field myocardium. Fixation, preparation and staining procedures 
were completed according to standard protocols8.
3-D reconstructions
We made 3-D reconstructions, as described previously8, of the composition of PV, LA 
dorsal wall and atrial septum of MLC-2a and 1A4 stained sections of podoplanin wild 
type and knockout embryos (E15.5). 
Morphometry 
Sinus venosus myocardial volume estimation was performed of 12 wildtype mouse 
hearts of E11.5 (n=3), E12.5 (n=3), E15.5 (n=3) and E18.5 (n=3) and 12 podoplanin 
knockout hearts of E11.5 (n=3), E12.5 (n=3), E15.5 (n=4) and E18.5 (n=2). Statistical 
analysis was performed with an independent sample-t-test (P<0.05) using SPSS 11.0 
software (SPSS Inc, Chicago, III) as described previously8.
Results
Podoplanin mutants demonstrate marked mesenchymal and myocardial 
abnormalities, including hypoplasia of the pro-epicardial organ, abnormal epicardium, 
hypoplastic chamber myocardium, atrial, ventricular and atrioventricular septal 
defects, and an abnormal coronary arterial vascular wall7,8. These abnormalities 
are related to diminished EMT which was reported in a previous paper8. Below, 
the morphological development of the wall of the PV, LA and atrial septum will be 
described in subsequent stages. Abnormal PV connections were not observed. In 
Table 1a sinus venosus myocardial volumes between wild type and knockout mice 
are compared. Table 1b provides an overview of qualitative expression of myocardial 









































Myocardial volume (mm3) SD Myocardial volume (mm3) SD
11.5 0.0094 (n=3) 0.0029 0.0050 (n=3) 0.0017 0.0457
12.5 0.0120 (n=3) 0.0025 0.0071 (n=3) 0.0032 0.0348
15.5 0.0424 (n=3) 0.0052 0.0300 (n=4) 0.0047 0.0108
18.5 0.2871 (n=3) 0.0307 0.1688 (n=2) 0.0287 0.0115
Expression of Markers
b
E Markers PV wall LA dorsal wall Atrial septum Media PV
WT Mutant WT Mutant WT Mutant WT Mutant
MLC2a ++ + ++ + Not 
10.5 Nkx2.5 ++ + ++ + Developed
Actin ++ + ++ + Yet
MLC2a ++ + +++ ++ +++ ++ ++ ++
12.5 Nkx2.5 ++ + ++ ++ ++ ++ ++ ++
Actin + + + + + + - -
MLC2a +++ +++ +++ +++ +++ +++ + +
15.5 Nkx2.5 +++ +++ +++ +++ +++ +++ + +
Actin - - - - - - ++ +
MLC2a +++ +++ +++ +++ +++ +++ - -
18.5 Nkx2.5 +++ +++ +++ +++ +++ +++ - -
Actin - - - - - - +++ +
Table 1. a: Sinus venosus myocardial volume estimation of 12 wild type (WT) and 12 
podoplanin-/- mouse hearts. In all stages, mutants have a significant smaller myocardial volume 
(P<0.05) compared to WT embryos. E: embryonic day, SD: standard deviation. b: A qualitative 
overview of the expression of markers at several locations in podoplanin WT and knockout 
(mutant) embryos. At early stages, the expression of all markers is diminished in mutants 
compared to the WT embryos, whereas in advanced stages these differences are no longer 
apparent, indicating delayed differentiation in mutants. Left atrium (LA); pulmonary vein (PV). 
+++strong, ++medium, +weak, -absent expression.
E10.5 
In the right part of the common atrium, the right and left venous valves delineated the 
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embryos, MLC2a was expressed in the sinus venosus and chamber myocardium 
(Fig.1a,c-e). In the mesenchyme of the dorsal mesocardium in wild type embryos, 
the lumen of the primitive PV was surrounded by a mainly left sided concentration of 
MLC2a positive myocardium that stained, however, less markedly for MLC2a compared 
to the common atrium (Fig.1a,d). In knockouts, this myocardium was thinner with 
clearly diminished MLC2a expression in a larger part in the dorsal mesocardium and 
left part of the atrial dorsal wall (compare Fig.1d with e). This diminished expression 
was seen in the region normally expressing podoplanin (Fig.1b, Table 1b). In wild 
types the primitive PV myocardium in the region of the dorsal mesocardium had 
mosaic Nkx2.5 expression, defined as a mixture of Nkx2.5 positive and negative 
cells. Similar to MLC2a expression, the Nkx2.5 mosaic myocardial cells were mainly 
situated on the left side of the dorsal mesocardium (Fig.1f). Moreover, in knockouts, 
this area was hypoplastic showing less Nkx2.5 expressing cells (compare Fig.1f with 
g). 
The alpha-smooth-muscle actin antibody 1A4 was co-expressed in the MLC2a-
stained myocardium of the common atrium and ventricle of the wild type embryos. 
Similar to MLC2a, actin expression around the primitive PV and left part of the atrial 
dorsal wall was weaker (Fig.1h). In mutants, actin expression was diminished in a 
larger region compared to the wild type (Fig.1i).
E12.5 
The common PV bifurcated into tiny left and right PVs, covered by a MLC2a positive 
myocardial layer which, in contrast to E10.5, could now be observed in equal density 
on both sides of the PV (Fig.2a,c). MLC2a expression around the PV was weaker than 
the expression in the myocardium of the atria (Fig.2a,c). In the dorsal mesocardium 
and around the PV Nkx2.5 expression was mosaic, while in the wall of the cardinal 
veins Nkx2.5 staining was negative (Fig.2d). In the atrial myocardium of the wild type 
embryos MLC2a as well as Nkx2.5 were positive, while smooth muscle actin had 
almost disappeared, particularly in the LA dorsal wall (Fig.2e). In the myocardium of 
the ventricles (not shown) and the wall of the cardinal veins (Fig.2e) smooth muscle 
actin was still present. Actin expression in the wall of the PV was more extensive than 




































In the podoplanin knockout embryos, MLC2a (Fig.2f,g) and actin positive (Fig.2i) as 
well as Nkx2.5 mosaic (Fig.2h) myocardium around the PV was thin and locally even 
absent (compare Fig.2a,c with f,g) in a region where podoplanin expression was seen 
in wild type embryos (Fig.2b). The LA dorsal wall and the atrial septum were thin 
and the myocardium was hypoplastic (compare Fig.2j,k with l,m). The atrial septum 
showed a large secondary foramen and myocardialization at the base of the atrial 
septum was absent (Fig.2k,m). Additionally, the atrioventricular cushion was not 
fused properly to the top of the ventricular septum resulting in a interventricular 
communication (Fig.2j,l). 
Figure 1. Transverse sections of podoplanin wild type (WT,a,b,d,f,h) and knockout (Podoplanin-/-,c,e,g,i) 
mouse embryos of stage (E)10.5 comparing the development of the pulmonary vein (PV). Boxed area in 
a and c are magnified in d and e. MLC2a expression is seen around the primitive PV on the left side of 
the dorsal mesocardium (DM) (a,d) where also podoplanin (b) and mosaic Nkx2.5 expression (f) is seen. 
Compared to the atrial myocardium (Amyo) the MLC2a expression at the DM and atrial (A) dorsal wall is 
weaker corresponding with the expression pattern of alpha-smooth-muscle actin (αSMA, h), which marks 
the developing myocardium. In knockouts, a larger region shows less expression of MLC2a (c,e), Nkx2.5 
(g) and αSMA (i), corresponding with altered differentiation rate of myocardium at these regions. Left 









































































Figure 2. Transverse sections of podoplanin wild type (WT,a-e,j,k) and knockout (Podoplanin-/-,f-i,l,m) 
mouse embryos of stage (E)12.5 comparing the development of the pulmonary vein (PV,a-i), atrial septum 
(AS,j-m) and left atrial (LA) dorsal wall (j-m). In WT embryos PV is surrounded by myocardium expressing 
MLC2a (a,c), podoplanin (b) and mosaic Nkx2.5 (d) and completely positive for alpha-smooth-muscle actin 
(αSMA,e). In mutants the expression of these markers around the PV is almost absent (compare a,c-e 
with f-i) and myocardium of the LA dorsal wall is hypoplastic (compare arrow in j,k with l,m). The AS in the 
knockouts is thin and deficient with a large secondary foramen (k,m). Moreover, myocardialization process 
of the AS with the deficient atrioventricular cushion (AVC, compare j with l) is absent (see arrowhead in 
k and m), which might cause an atrioventricular septal defect. Boxed area in a,f,j and l are magnified in 
c,g,k and m. Left cardinal vein (LCV), Right atrium (RA), Right cardinal vein (RCV). Scale bars a-i,k,m 30μm, 
j,l 200 μm.
E15.5 
In both wild types and knockouts, the myocardium of the atria, the atrial septum 
and of the wall of the cardinal and PVs expressed MLC2a (Fig.3a-f). In mutants, the 
myocardium of the atrial septum and the PVs was hypoplastic (compare Fig.3c,d with 
e,f). Moreover, compared to wild type, the PVs in knockout embryos seemed to be 
dilated (compare Fig.3c with e). In both wild type and knockout embryos, the Nkx2.5 
mosaic expression in the wall of the PV became overall positive (Fig.3g,i). 
In wild type embryos 1A4 co-staining was specifically observed in the MLC2a positive 
sub-endothelial layer of the PVs and LA dorsal wall (Fig.3h). In the outer MLC2a 
positive myocardial layer of the wall of the PVs, cardinal veins, dorsal atrial wall and 
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knockout embryos, smooth muscle actin was almost absent in the sub-endothelial 
layer of the PVs and LA dorsal wall, which still showed MLC2a staining (compare 
Fig.3a,h with b,j). In areas with 1A4 expression, distribution of positive cells was 
discontinuous compared to the wild type embryos (compare Fig.3h with j).
E18.5 
The common part of the PVs was incorporated into the LA. In both wild type and 
knockout embryos MLC2a expressing myocardium was seen in the atria and the 
wall of the cardinal and PVs, while the myocardium now extended into the lungs 
(Fig.4a,b). Similar to previous stages, the myocardium was hypoplastic in knockouts, 
with dilation of the atria, the cardinal and PVs (compare Fig.4a,b with c,d). In the 
dorsal mesocardium less mesenchymal cells were observed compared to the wild 
type (compare asterisk in Fig.4 a with b). 
In the PV and LA dorsal wall of the wild type embryos, smooth muscle actin (1A4) 
was present between endothelium and MLC2a positive myocardium (Fig.4e). 
Hence, the 1A4 positive actin layer was MLC2a negative in contrast to the previous 
stages (compare Fig.3d,h with Fig.4c,e). The 1A4 staining at other parts of the heart 
was absent (not shown), except for the wall of the cardinal veins and ventricular 
myocardium. Again, hardly any 1A4 staining was seen in the sub-endothelial layer 





































Figure 3. 3-D reconstructions (a-b) and transverse sections (c-j) of podoplanin wild type (WT,a,c,d,g,h) and 
knockout (Podoplanin -/-,b,e,f,i,j) mouse embryos of stage (E)15.5 showing hypoplasia of atrial septum 
(AS) and altered smooth muscle cells (SMC,red) formation in the wall of the common pulmonary vein (PV) 
and the posterior wall of left atrium (LA) of the mutants. a and b are a cranial view of the PV orifice into the 
LA showing the diminished amount of SMCs in the PV and LA dorsal wall in knockouts. Boxes in c and e are 
the positions of the enlargements in d and f. Compared to WT embryos, the MLC2a positive myocardium 
of the AS, the left cardinal vein (LCV) and the somewhat dilated PVs in knockouts is hypoplastic with 
interposition of less mesenchymal tissue (compare c,d with e,f). The myocardium of the wall of the PV is 
differentiated and is seen as a myocardial cuff around the PV, which expresses Nkx2.5 (g,i). In WT embryos 
SMCs (arrowheads in h) are incorporated into the LA, whereas in knockouts SMCs are almost absent 
(arrowheads in j). Mitral valve (MV,yellow), Right atrium lumen (RA,light gray), Right cardinal vein lumen 
(RCV,light gray), tricuspid valve (TV,yellow). Color codes: light gray (lumen), dark gray (MLC2a positive 
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Figure 4. Transverse sections of podoplanin wild type (WT,a,c,e) and knockout (Podoplanin-/-,b,d,f) mouse 
embryos of stage (E) 18.5 comparing the development of pulmonary vein (PV). Sections a-d are stained 
with MLC2a as myocardial marker and sections e and f are stained with alpha-smooth-muscle cell actin 
(αSMA). Boxes in a,b are the positions of the enlargements in c,d. a,b. MLC2a expression is seen in WT 
and mutants in the myocardium of left (LA) and right atrium (RA), left cardinal vein (LCV) and pulmonary 
veins (PV) (a,b). In knockouts, these structures are dilated and have hypoplastic myocardium (arrowheads 
in a-d) with interposition of less mesenchymal tissue (a,b; asterisks). Smooth muscle cells (SMC) are seen 
in the sub-endothelial layer of the PV and LA dorsal wall (arrows in e). In the mutants, SMCs are almost 
absent, which might be caused by either impaired SMC formation or differentiation due to the lack of 





































During human development, a vascular lining comprising SMCs and an adventitia will 
evolve at the inside of the LA body, that is lined on the outside by atrial myocardium14. 
Findings in the current study show a similar phenomenon in the LA of wild type 
mouse embryos. A difference between mouse and human specimen concerns the 
extension of the myocardial tissue surrounding the PV into the lung. The merits of 
our current study are that the posterior heart field plays a role in the addition of not 
only PV myocardium, but also in the formation and differentiation of SMCs that line 
the LA body. We demonstrated hypoplasia of the myocardium of the PV, LA dorsal 
wall and the atrial septum in podoplanin knockout mice. The vessel wall of the PVs 
and its extension into the LA was underdeveloped in knockout embryos.
Myocardial development
It has been reported earlier that the myocardial sleeve around the PV is formed 
by either migration of existing atrial cardiomyocytes1, or by recruitment and 
differentiation of mesenchymal cells of the splanchnic mesoderm2. The latter 
supports earlier advances in the study of cardiac development that underline the 
relevance of addition of myocardium to the primary heart tube15. The second heart 
field5 or second lineage4,5 concerns an anteroposterior extension of splanchnic 
mesenchyme from where cells are recruited for addition to both the arterial pole and 
the venous pole of the heart. Several studies have been performed using different 
lineage markers such as fibroblast growth factor (Fgf)8 and 1016, Islet (Isl)15 and Tbx1 
and 1817,18 to trace these cells into their cardiac destination. Special interest was 
raised in markers specific for recruitment of myocardium from the second heart field 
to the venous pole of the heart such as Pitx2c3, Nkx2.53,7, Shox219 and podoplanin7,8.
Podoplanin promotes EMT by binding ERM proteins that activate RhoA and by 
downregulation of the cell-to-cell adhesion molecule E-cadherin8,9. In podoplanin 
knockout mice E-cadherin is upregulated causing abnormal EMT which may lead 
to abnormal formation of myocardium at the venous pole of the heart8. Thus, the 
hypoplasia of the myocardium of the wall of the PVs, atrial septum and LA dorsal 
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by impaired addition of myocardium from the posterior heart field due to abnormal 
EMT by lack of podoplanin.
Another explanation for the myocardial hypoplasia in the podoplanin knockouts 
could be abnormal epicardial-myocardial interaction. Previously we demonstrated 
that altered epicardial-myocardial interaction leads to deficient ventricular 
myocardial formation in SP3 mutants20 as well as in podoplanin mutant embryos8. 
In SP3 mutants, WT-1 expression, a transcription factor involved in development 
of epicardium derived cells (EPDCs)21, was downregulated and the mutant hearts 
showed EPDC-related cardiac abnormalities comparable to podoplanin mutants. 
The impaired formation of EPDCs and altered epicardial-myocardial interaction, 
resulting in hypoplastic atrial and ventricular myocardium in podoplanin knockouts, 
has already been described and related to the deficient contribution of the posterior 
heart field8,22. Therefore, the hypoplasia of the PVs, atrial septum and LA dorsal 
wall reported in the current study could be related to the altered contribution of 
epicardium and myocardium from the posterior heart field. 
In early stages, Nkx2.5 and alpha-smooth-muscle actin (1A4) are expressed in 
undifferentiated myocardium. At these stages, Nkx2.5 is mosaic around the PVs and 
absent in the wall of the cardinal veins7, whereas actin expression is present in the 
wall of the pulmonary and cardinal veins. The Nkx2.5 mosaic expression in the wall of 
the PVs rapidly becomes completely positive concomitant with a higher proliferation 
rate of the PV myocardium compared to the cardinal veins3. Consequently, 1A4 
expression from E15.5 on is confined to the medial layer of the vascular wall of 
the pulmonary and cardinal veins. These findings suggest that the pulmonary and 
cardinal veins have a common precursor derived from the posterior heart field7, but 
a distinct proliferation rate3 accounting for a distinct differentiation based on Nkx2.5 
expression. 
Expression of markers in putative PV myocardium starts at the left side of the dorsal 
mesocardium, indicating that PV myocardium is preferentially added from the left 
side of the posterior heart field, regulated by progenitor cells that play a role in left-
right patterning, as was reported for Pitx2c3,23,24. Next to hypoplasia, mutants showed 
diminished expression, that was predominantly observed in the earlier stages (Table 
1a,b). As in later stages these differences were no longer apparent, this suggests a 




































Smooth muscle cell development 
The origin of the SMCs at the venous pole is as yet not well understood. SMCs 
may differentiate from mesenchymal cells6. At the arterial pole formation and 
differentiation of SMCs has been reported from the splanchnic mesoderm or from 
the neural crest25. The latter process requires cross-talk between the endothelial and 
the muscular component26. DeRuiter and colleagues have described the formation of 
the SMCs of the dorsal aorta by transdifferentiation from endothelial cells27.
Research in this field is complicated as alpha-smooth-muscle actin also stains the 
primitive myocardium. We demonstrated that this staining was less extensive in 
the developing myocardium of the podoplanin mutant mice, supporting delayed 
or defective myocardial differentiation. At the stage that normally alpha-smooth-
muscle actin disappears from the myocardium, only the SMCs retain their expression 
of this marker. In podoplanin knockout mice we observed a diminished extension 
of SMCs in the LA dorsal wall as compared to normal. This phenomenon may be 
caused by impaired formation of SMCs from the posterior heart field derived dorsal 
mesocardium or abnormal or delayed differentiation of the SMCs in the PV and LA 
body in absence of podoplanin. The disturbed EMT in podoplanin knockouts probably 
leads to abnormal formation of SMCs as was shown for the coronary artery SMCs 
development in mutant mice8.
In conclusion, as podoplanin is a marker of the myocardial and mesenchymal cells 
derived from the second heart field at the venous pole of the heart, this study 
supports evidence that the myocardium of the PVs, LA dorsal wall and atrial septum 
is derived from the posterior heart field. Moreover, we can state that podoplanin not 
only plays a role in the development of myocardium, but also in the formation of the 
SMCs.
The clinical relevance of our findings needs further research. In the mutants, complex 
atrial defects were observed. In the majority, there was fusion of the primary atrial 
septum with the AV cushions, but the secondary foramen was enlarged and the AV 
cushions did not fuse properly with the ventricular septum resulting in an AVSD with 
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The study of human and mouse models with isomerism, atrial arrhythmias and cases 
with abnormal pulmonary venous return are on their way. More insight into the 
variation in myocardial cuffing of the PVs in the human population might enlighten us 
on the variability of occurrence of ectopic automaticity in the PV myocardial sleeve28, 
which is suggested by the finding that the length of the PV sleeve corresponds to 
the frequency of occurrence of ectopic PV beats as observed in electrophysiological 
studies28,29. In podoplanin knockout embryos, we have observed deficient sinus 
venosus myocardium with myocardial discontinuities. Areas lacking myocardium 
can be regarded as low voltage areas (comparable to scar tissue) that may form the 
substrate of reentry circuits. Electrophysiological testing in mutant mice is necessary 
to further investigate this hypothesis.
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Background. Normally, the inside of the left atrial (LA) body and pulmonary 
veins (PVs) is lined by vessel wall tissue covered by myocardium. In total 
anomalous pulmonary venous connection (TAPVC), no connection of the 
PVs with the LA body exists. These veins have an increased incidence of PV 
stenosis. We describe the consequences of the absent connection for the 
histopathology of the wall of the LA body and the PVs, and hypothesize on a 
mechanism predisposing to PV stenosis.
Methods and results. In 10 human neonates with TAPVC, the wall of the 
LA body and PVs were studied using histological and immunohistochemical 
techniques. As controls, 2 normal neonatal and adult hearts and 5 neonatal 
hearts with partial anomalous venous connection (PAPVC) or situs inversus 
were studied. In hearts with TAPVC, no vessel wall tissue was found in the 
LA body and its myocardial layer was hypoplastic. No myocardial sleeve was 
found around the abnormally draining PVs. In hearts with PAPVC, only the 
non-LA draining PV lacked myocardial covering, whereas in situs inversus, PVs 
connecting to the right-sided LA, were normally myocardialized. 
Conclusion. An open connection of the PVs with the morphological LA is 
necessary for the presence of vessel wall tissue in the LA and myocardialization 
of the PVs. Absence of myocardium covering the PVs is hypothesized to 
enhance susceptibility to PV stenosis and prevent onset of PV originating 
arrhythmias. The embryonic posterior heart field may be responsible for the 







































In human cardiac development, at the end of the fifth week, in the dorsal 
mesocardium the common pulmonary vein (PV) lumenizes, thus forming an open 
connection between the pulmonary vascular network and the left atrium (LA)1-4. 
Therefore, connections to the systemic circulation3,5 have become non-functional 
and regress. Thereafter, a myocardial sleeve, which is continuous with the LA 
myocardium, is formed around the common PV. The origin of this myocardial 
layer lining the PVs is a topic of debate. Either LA cardiomyocytes extend into the 
extracardiac mesenchyme and cover the PVs6-8, or non-cardiac cells are recruited 
from the splanchnic mesenchyme and differentiate into myocardial cells which line 
the PVs9-11. Recently, in mice a biphasic process of formation of PV myocardium was 
described, favouring both points of view12.
From the tenth week onwards, the PVs grow and are incorporated into the also 
expanding dorsal wall of the LA. This process results in a smooth-walled LA body 
consisting of vessel wall tissue on the inner side covered by myocardium on the 
outside13. In hearts with total anomalous pulmonary venous connection (TAPVC), the 
common PV forms no open connection between the splanchnic plexus and the LA, thus 
resulting in persistence of (one of) the cardinal veins draining the pulmonary venous 
blood to the systemic venous circulation3 which can be divided in a supracardiac, 
a cardiac and a infracardiac type of drainage. At presentation and especially after 
repair of anomalous pulmonary venous connections, increased rates of PV stenosis 
are reported, suggesting susceptibility of these veins to PV stenosis14-16. A remarkably 
low incidence of significant arrhythmias in these patients is reported in literature17.
Our previous findings13 have shown that the common PV connects to and incorporates 
into the expanding LA dorsal wall resulting in vessel wall tissue lining the smooth wall 
of the LA and a covering of the PVs by a myocardial layer. We hypothesize that, if 
this process does not take place, as in hearts with TAPVC, there will be an abnormal 
histology of the structures involved, which may also have clinical consequences. We 
also postulate on the basis of mouse model studies12 that PV myocardialization is a 





































We studied 5 neonatal heart-lung specimens from the Leiden collection with 
supracardiac (n=4) or infracardiac (n=1) TAPVC as well as biopsy material of another 
5 neonates, taken intra-operatively prior to surgical correction, of either the 
supracardiac (n=3) or infracardiac (n=2) type of TAPVC. These patients were operated 
in the University Medical Center of Groningen or Rotterdam. The local Medical Ethical 
Committee approved the studies. The age of the neonates ranged from 1 day to 2 
years. Hearts with atrial isomerism were excluded.
Controls. 
Normal neonatal (n=2) and adult hearts (n=2) were used as controls. Three neonatal 
heart-lung specimens from the Leiden collection with cardiac (n=1) and supracardiac 
(n=2) partial abnormal pulmonary venous connection (PAPVC) were used to study 
the myocardialization process of PVs when normal and abnormal pulmonary venous 
drainage coexist. We additionally examined two neonatal heart-lung specimens with 
situs inversus to study the influence of laterality, in this case of a right-sided position 
of the LA, on the myocardialization of the PVs.
The adult hearts were obtained from human bodies used in anatomy teaching 
lessons. The cause of death was unknown due to privacy regulations.
Samples/sectioning of material:
Study material. From the neonatal heart-lung specimens with TAPVC, tissue blocks 
were taken from the dorsal wall of the smooth-walled LA body, the LA appendage 
and the PVs. The surgical biopsies obtained from patients of the University Medical 
Center of Groningen and Erasmus Medical Center Rotterdam were derived from the 
LA dorsal wall and the pulmonary venous confluence (exactly taken at the site of the 
incisions necessary for the correction) and, in some cases, the vertical vein. 
Controls.
Normal neonatal and adult hearts. Tissue blocks were taken from the LA dorsal 
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posterior and anterior right atrial (RA) body, the RA appendage, both caval veins, the 
smooth-walled RA body above the tricuspid valve and the coronary sinus to compare 
the presence of vessel wall in the LA and RA. 
Neonatal hearts with abnormalities. From the specimens with PAPVC, samples of the 
normally as well as abnormally draining PVs were taken. In hearts with situs inversus, 
tissue blocks were taken from the PV-LA transition. 
The samples were embedded in paraffin and sectioned (5 mm) using a Leica 
microtome. The sections were mounted onto slides using chicken albumin dissolved 
in glycerine (1:1) and dried at 37 °C for ≥ 24 h. 
Staining: Standard histological staining procedures were performed with 
Hematoxylin-Eosin, Verhoeff-Van Gieson or elastic Resorcin-Fuchsin to detect elastic 
filaments. Additional sections were stained immunohistochemically with a mouse 
monoclonal against alpha smooth muscle (SM) actin (1A4, 1:10.000, Sigma Aldrich, 
Product No. A2547, USA), indicating the presence of a vascular wall, and a rabbit 
polyclonal antibody against atrial myosin light chain (MLC2a, 1:2000, a generous gift 
of Steve Kubalak), specific for atrial myocardium. After incubation with the primary 
antibodies overnight, antibody binding for 1A4 was demonstrated with rabbit anti-
mouse peroxidase (RAM-PO, 1:250, Dako, Product No. P0260, Denmark) and for 
MLC2a with goat anti-rabbit biotin (GAR-biotin, 1:200, Vector labs, Product No. BA-
1000, USA). The latter procedure was followed by a rabbit biotinylated reagent (ABC, 
1:100, Vector Labs, Product No. PK-6100). After sections were rinsed with phosphate 
buffered saline and tris/maleate (pH 7.6), 3-3’ diaminobenzidine tetrahydrochloride 
(DAB) was used as chromogen and counterstaining was performed with Mayer’s 






































Normal neonatal and adult hearts.
In the PVs, a characteristic venous vessel wall was found, consisting of an intimal 
layer, a medial layer with smooth muscle cells, embedded in a matrix of collagen 
and elastic fibers and an adventitial layer with fibroblasts and vasa vasorum. On the 
outside, the PVs were covered by a myocardial sleeve which tapered off towards 
the lung hilum. In the entire smooth-walled LA body, a prominent vessel wall layer, 
continuous with that of the PVs, was found, covered on the outside by myocardium. 
At the transition of the PV ostia and the LA body no histologic veno-atrial demarcation 
was found. In contrast to the neonatal hearts, in the PVs and LA body of adult hearts 
intimal thickening was observed, most profound in the PVs (Fig.1a-f). 
The RA dorsal wall of the adult hearts was smooth-walled and consisted of 
myocardium. The inner side of the RA body wall near the superior caval vein consisted 
of a layer of endocardium overlying a discontinuous layer of elastic fibers, generally 
indicated as the lamina elastica interna. Between these layers and the myocardium, a 
vascular tunica media was observed, continuous with that of the superior caval vein 
(Fig.2a,b). This smooth muscle cell layer was also seen in the region of the orifice of 
the inferior caval vein. In the circumference of the orifice of the coronary sinus no 
smooth muscle cells were found. The coronary sinus itself contained a proper tunica 
media as seen in the superior caval vein, covered on the outside by a myocardial 
layer (Fig.2c,e). In the remaining part of the smooth-walled RA body no vessel wall 
tissue was observed (Fig.2c,d). 
The RA and LA appendages were trabeculated and lined by endocardium with a 
subendocardial presence of elastin and collagen fibers and an occasional smooth 








































Sections of a normal neonatal heart (a-d) and adult heart (e,f) stained with elastic Resorcin-Fuchsin (a,c; 
Elastin) and alpha smooth muscle actin (b,d-f; SM actin), showing the histological structure of pulmonary 
venous and left atrial wall. Boxes in a,b indicate the positions of the enlargements in c,d.
a-d. At the anatomical transition of pulmonary veins (PV) and LA body (LAB), no histologic veno-atrial 
demarcation is found. The wall consists of endothelium/endocardium, a medial layer (M), with smooth 
muscle cells and elastic fibers, an adventitial layer (A), myocardium (Myo), and an outer epicardium (E).
e,f. In the PV as well as in the LAB, conforming to the sections in a-d, an identical and characteristic vessel 
wall is found. In contrast to the neonatal stage profound intimal thickening (I) is observed most obviously 










































































Sections of the right atrial body of normal adult hearts, stained with Verhoeff-Van Gieson (a,c,f; Elastin) 
and alpha smooth muscle actin (b,d,e,g; SM actin). Boxes in c indicate the positions of the enlargements 
in d,e.
a,b. Right atrial body (RAB) near the superior caval vein showing organized vessel wall tissue with multiple 
layers of smooth muscle cells. Intima (arrow).
c-e. In the region next to the coronary sinus (CS), no vessel wall tissue is found, which is representative 
for the major part of the smooth-walled RAB. The CS is covered by myocardium. Endothelium (arrow).
f,g. Trabeculated RA appendage (RAA). On the inner surface a thin endocardium (arrow) is present and a 
subendocardial layer with elastic fibers, collagen and occasional smooth muscle cells. There is no proper 
tunica media. These thin layers are covered by myocardium. 
adventitia (A), Lumen (L), media (M), myocardium (Myo). Scale bar = 100 µm in a,b,d-g; 300µm in c.
Heart-lung specimens with abnormal PV connections. 
Macroscopic findings. Two of the four hearts with the supracardiac type of TAPVC 
had a situs solitus of the atria, with concordant atrioventricular and ventriculo-
arterial connections, a small mitral valve and a hypoplastic left ventricle. Both had a 
secundum type of atrial septal defect (ASD), one of which had been surgically closed. 
The PV confluence originally drained via a vertical vein into a systemic vein, in this 
case the brachiocephalic vein. In the surgically corrected heart, the vertical vein 
was ligated and the PV confluence was connected to the roof of the LA body, thus 
establishing a continuous blood flow from the PVs to the LA. One of the other two 
hearts had a discordant ventriculo-arterial connection, with pulmonary atresia. The 
other heart had a double outlet right ventricle with infundibular pulmonary stenosis. 
Both of these hearts had a secundum type of ASD as well as an atrioventricular septal 
defect (AVSD).
The heart with the infracardiac type of TAPVC also presented with a situs solitus 
of the atria. There was a concordant atrioventricular connection with mitral atresia 
and a discordant ventriculo-arterial connection. The LA body and the enlarged RA 
body were smooth-walled. A secundum type of ASD was present. The PV confluence 
connected to a vertical vein, which descended through the diaphragm to a systemic 
vein, in this case the right gastro-epiploic vein that drained into the portal vein. 
The three neonatal heart-lung specimens with PAPVC had a situs solitus, with 
concordant atrioventricular connections. In two specimens, the ventriculo-arterial 
connections were discordant. One of the four PVs drained either directly or via the 
brachiocephalic vein into the right superior caval vein in two of the three specimens, 
and in one the right PVs originally drained directly into the RA which was operatively 
corrected. Besides a ventricular septal defect (VSD) in two, there were no other 




































The hearts with situs inversus both had concordant atrioventricular and ventriculo-
arterial connections with a right-sided aortic arch. In one a subaortic stenosis, 
dysplastic aortic valve, secundum type of ASD and an AVSD were present, the other 
had a perimembranous subaortic VSD.
Microscopic findings. In both the supra- and infracardiac type of TAPVC, the wall of the 
PV confluence had an intimal, medial and an adventitial layer. The intima consisted 
of an endothelial layer, a subendothelial layer of collagen and a clear lamina elastica 
interna with well-oriented elastic fibers. The media consisted of smooth muscle cells 
embedded in collagen and some elastic fibers. The adventitial layer had randomly 
distributed collagen fibers, some elastic fibers and scattered smooth muscle cells. 
Interestingly, in contrast to normally connecting PVs, no myocardial layer was 
observed around the anomalous connecting PVs (Fig.3a,b). 
The posterior wall of the smooth-walled LA body consisted of a slightly thickened 
subendocardial layer of collagen, elastic fibers and sporadic smooth muscle cells, 
covered by myocardium. In contrast to the normal LA body, no distinct vessel wall 
tissue was observed (Fig.3c,d). Moreover, compared to normal, the size of the LA 
body was significantly diminished and its myocardial layer was translucent and 
hypoplastic (Fig.4a-d). In one case, even spongious (non-compact) LA myocardium 
was seen (not shown). Similar to the RA appendage in normal hearts (Fig.2f,g), the 
LA appendage was trabeculated and consisted of an endocardial layer covered by 
myocardium. 
In the heart-lung specimens with either cardiac or supracardiac PAPVC, the PVs 
that connected to the LA were normally myocardialized (not shown), whereas 
the abnormally draining veins (i.e. the veins that did not connect to the LA) had 
no myocardial covering (Fig.5a-d). Moreover, similar to normal hearts, in cardiac 
PAPVC no vessel wall tissue was found in the RA body (not shown). The heart-lung 
specimens with situs inversus showed normally myocardialized PVs connecting to the 







































Sections of neonatal heart-lung specimens stained with 1A4 against alpha smooth muscle actin (a,c; SM 
actin) and atrial myosin light chain (b,d; MLC2a), showing the histological structure of pulmonary venous 
and left atrial wall in hearts with total anomalous pulmonary venous connection (TAPVC).
a,b. Pulmonary venous (PV) confluence representative for any kind of TAPVC showing vessel wall consisting 
of a tunica intima (arrow), media (M) and a tunica adventitia (A) without myocardial covering. 
c,d. Smooth-walled left atrial body (LAB) with a slightly thickened (sub)endocardial layer (arrow, double 
head) of collagen, elastic fibers and occasional smooth muscle cells covered by myocardium (Myo). No 
vessel wall tissue was found.





































Pictures of a normal neonatal heart (a) and a neonatal heart with the supracardiac type of TAPVC (b) 
correlated to sections of their LA dorsal wall stained with atrial myosin light chain (c,d; MLC2a).
a. Normal heart. The left atrial body (LAB, between dotted lines) receives the PVs and is demarcated by 
the ligament of Marshall (LM), at the base of the left atrial appendage (LAA), and the atrial septum (IAS). 
b. Supracardiac type of TAPVC. The pulmonary veins (PV) are not connected to the LAB but drain via a 
confluence into the systemic venous circulation. In this case, the LM connects the PV confluence to the left 
atrium. Note that in TAPVC, the size of the LAB (between dotted lines) is remarkably diminished and that 
there is more translucency compared to the normal heart.
c. Normal heart. The myocardium (Myo) of the LAB has a normal, compact structure.
d. TAPVC. Compared to the normal heart, the myocardium is hypoplastic, causing translucency.







































Sections of neonatal heart-lung specimens stained with Verhoeff-Van Gieson for elastic filaments (a,c,e; 
Elastin) and atrial myosin light chain (b,d,f; MLC2a), showing the histological structure of the abnormally 
draining pulmonary vein (PV) in partial anomalous pulmonary venous connection (PAPVC; a-d) as well as 
the histological structure of the PV in case of situs inversus (e,f).
a,b. Extracardiac PAPVC. Section of the abnormally draining PV showing a normal vessel wall structure (a), 
and absence of myocardium (b). 
c,d. Cardiac PAPVC. The right atrial body (RAB) receives one of the PVs. This PV is not myocardialized.
e,f. Situs inversus. The PVs, though right-sided, do have a myocardial layer.




































Biopsies of patients during surgical correction for TAPVC 
Macroscopic findings. In all hearts with the supracardiac type, the PV confluence 
drained by means of a vertical vein into the brachiocephalic vein. Naturally, in hearts 
with the infracardiac type, only a vertical vein descending downwards could be 
identified during operation. In none of these 5 hearts other cardiac anomalies were 
found. 
Microscopic findings. Within the samples taken from the smooth-walled LA body, 
no vessel wall tissue was detected. The smooth-walled LA body consisted of 
endocardium and a subendocardial layer, the latter consisting of randomly scattered 
collagen and elastic fibers, covered by myocardium (Fig.6a-c). The PV confluence 
consisted of a well organized subendothelial layer of collagen and elastic fibers. The 
medial layer resembled a proper tunica media and consisted of multiple layers of 
smooth muscle cells embedded in collagen and some elastic fibers (Fig.6d,e). On the 
outside of the confluence a proper tunica adventitia was observed. Again, in these 
veins, no myocardial layer surrounding the vein was present (Fig.6f). Samples of the 
vertical vein could be taken in two hearts with the supracardiac type and in two 
hearts with the infracardiac type. In both types the intimal layer was locally thickened 
(not shown). As in the sections of the anomalous connecting PVs, no myocardial layer 
was observed (Fig.6g-i). 
Figure 6a-i
Sections of peroperatively taken samples of left atrial body (LAB), pulmonary veins (PV), and the vertical 
vein (VV) from neonates operated on for total anomalous pulmonary venous connection. Staining with 
elastic Resorcin-Fuchsin (b,h; Elastin) and Verhoeff-Van Gieson (e; Elastin) for elastic filaments; alpha 
smooth muscle actin (a,d,g; SM actin), and atrial myosin light chain (c,f,i; MLC2a). 
a-c. Smooth-walled LAB, showing absence of vessel wall tissue (a). The thin endocardium (b,arrow) and 
subendocardial layer with collagen and elastic fibers (b), is covered by myocardium (c, Myo).
d-f. PV confluence consisting of proper vessel wall components (d,e) but lacking a myocardial covering (f).
g-i. Vertical vein histologically resembling the PV confluence with absence of myocardial covering (i). 







































In this study we examined the morphology and tissue characteristics of hearts from 
patients with anomalous pulmonary venous connections, and compared the results 
with findings in normal controls. Key findings of our study in patients with TAPVC 
are: 1. a significantly diminished size of the LA body and reduced thickness of the 
myocardium; 2. the lack of a vessel wall in the LA body; and 3. the lack of formation 
of a myocardial muscular sleeve surrounding the PVs.
The origin of the myocardium surrounding the common PV in normal hearts remains 
an issue of debate. On the basis of morphology and expression patterns of the 
marker HNK-1 in avian18, rat19 and human20 embryos and Nkx2.5 expression in human 
embryos9, our group showed that the myocardium around the common PV belongs 
to the sinus venosus segment. Based on morphology4,21 and expression patterns of 




































PV can be discriminated from the myocardium of the primary heart tube. There are 
different theories about the (secondary) addition of myocardium lining the common 
PV.
Recent research using the novel coelomic and myocardial marker podoplanin, has 
shown that the development of sinus venosus myocardium, derived by recruitment 
of progenitor cells at the venous pole (the so-called posterior heart field), and 
surrounding the common PV, is demarcated by podoplanin expression and the 
absence of Nkx2.5 expression.
Compared to the rest of the sinus venosus myocardium, the PV myocardium 
undergoes a rapid differentiation and proliferation phase12, during which the Nkx2.5 
expression changes from a mosaic to positive expression pattern9. Diminished 
Nkx2.5 expression is accompanied by expression of the sinus venosus marker HCN4 
in the PV myocardium12, suggesting early transient expression of HCN4 in the PVs 
during the mosaic Nkx2.5 expression phase. Eventually, HCN4 becomes confined 
to the sino-atrial node12. The myocardium surrounding the common PV is linked 
to the development of parts of the cardiac conduction system9,12. These findings 
are supported by the (transient) expression of several molecular markers in the 
myocardial sleeve surrounding the PV, including HNK-1 and CCS-lacZ20,23. Therefore, 
second heart field derived myocardial cells surrounding the PVs may have conduction 
properties responsible, together with areas of myocardial discontinuity, for the 
increased susceptibility for arrhythmias arising from the PV area and the LA dorsal 
wall10,13,24. We postulate that the lack of a myocardial sleeve surrounding the PVs in 
patients with TAPVC, may explain the low incidence of arrhythmias observed in this 
patient group17.
Since in TAPVC hearts addition of myocardium at the venous pole is impaired, also 
sino-atrial node dysfunction can be expected. This hypothesis is supported by several 
clinical studies17,25 as well as by the observation that in podoplanin knockout mice, 
the sino-atrial node is hypoplastic26.
The findings of our current study that in human hearts with supra- or infracardiac 
TAPVC, myocardium around the PVs is absent, the LA myocardium is hypoplastic 
and no vessel wall tissue is found in the LA body, suggest that impaired formation 
and differentiation of posterior heart field myocardial and smooth muscle cells 
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As we have shown, in hearts with TAPVC, as a consequence of absent PV connection 
and incorporation, the complete LA body is small and smooth-walled, and the 
myocardium is hypoplastic. Additionally, reduced fetal hemodynamic flow may 
contribute to the observed small size of the LA in these hearts. Therefore, it is 
not surprising that surgeons have tried to optimize results of TAPVC correction by 
augmentation of the LA15,27.
In this study, in one heart with TAPVC, non-compaction of LA myocardium was seen. 
Since the posterior heart field seems to contribute to TAPVC and the proepicardial 
organ is derived from the posterior heart field, an explanation for the spongious LA 
myocardium can be impaired formation of epicardium derived cells (EPDC’s) and 
altered epicardial-myocardial interaction, which are known to be responsible for 
abnormal atrial and ventricular myocardium28,29.
In our study in 60% of TAPVC heart-lung specimens also outflow tract abnormalities 
were found. Because the posterior heart field is part of the second heart field which 
contributes to myocardial addition at the arterial as well as the venous pole30, co-
existence of outflow tract and inflow tract abnormalities can be explained. 
We hypothesize that an open connection of the common PV into the morphological 
LA is necessary to trigger recruitment of mediastinal mesenchymal cells, that 
subsequently differentiate into cardiomyocytes and smooth muscle cells. Based on 
our findings in hearts with (extra)cardiac PAPVC and in situs inversus, we now know 
that only PVs connecting to the LA body are myocardialized (Fig.7a-h). This is an 
important finding which confirms that for PVs, addition of myocardial cells recruited 
from the posterior heart field, mainly takes place from the morphological left side9. 
In this context, an interesting finding in hearts with cardiac TAPVC and isomeric 
left atrial appendages was that myocardialization was only found in one “LA”, 
irrespective of the side of PV incorporation. This myocardialization is probably based 
on left-right patterning as was shown in studies using the left-sided transcription 
factor Pitx2c12,31,32. Pitx2c deficient mice exhibit right atrial isomerism and lack the 










































































Schematic depiction of outer (a,c,e,g,i) and inner (b,d,f,h,j) side of atrial chambers and pulmonary veins 
(PV) in normal hearts (a,b), hearts with total anomalous pulmonary venous connection (TAPVC;c,d), 
hearts with (extra)cardiac partial anomalous pulmonary venous connection (PAPVC; e-h) and hearts with 
situs inversus (i,j).
a,b. Normal heart. a. Left atrial body (LAB) and pulmonary veins (PV) covered by myocardium derived from 
the posterior heart field (dark blue). In the area between the PVs the myocardium can be discontinuous or 
absent. Right atrial body (RAB) covered by sinus venosus myocardium (light blue). b. The inner aspect of 
both LAB and RAB is smooth-walled. In the LAB vessel wall tissue (red) is found parallel to PV incorporation. 
The left and right atrial appendages (LAA, RAA) consist of trabeculated myocardium (brown).
c,d. TAPVC, extracardiac type. The PVs drain via a vertical vein (VV) into a systemic vein (SV) and are not 
covered by myocardium. The LAB consists of smooth-walled hypoplastic myocardium, derived from the 
posterior heart field. Because of the absence of PV connection and incorporation into the LA, the LAB is 
small. Moreover the LAB does not contain vessel wall tissue, probably because of impaired differentiation 
of smooth muscle cells. 
e,f. PAPVC, cardiac type. The abnormally connected PV drains directly into the RAB, but no vessel wall 
tissue is found in the RAB. In contrast to the PVs that are connected to the LAB, the abnormal PV is not 
covered by myocardium.
g,h. PAPVC, extracardiac type. The abnormally connected PV drains (in)directly into the superior caval vein 
and is, similar to the cardiac type of PAPVC, not covered by myocardium. The LAB and its incorporated PVs 
are myocardialized and comparable to the normal heart, vessel wall tissue is present in the LAB. 
i,j. Situs inversus. The LAB is located on the right side of the heart and receives the four PVs, which are 
covered by myocardium. In the LAB vessel wall is found parallel to normal PV incorporation.
Coronary sinus (CS), inferior caval vein (IVC), pulmonary venous confluence (PVC), superior caval vein 
(SCV).
After surgical correction of TAPVC, the pulmonary venous confluence is connected 
with the LA body. Because of an increased incidence of PV stenosis at the site of the 
anastomosis, so-called sutureless techniques have been developed and successfully 
applied33,34. We hypothesize that this PV stenosis might be enhanced in TAPVC by 
differences in wall thickness and contractile properties of cells at the transition of PVs 
to LA, where vessel wall is directly sutured to myocardium, without an intermediate 
layer of myocardium protecting the PV. Also, primary PV stenosis is observed 
frequently in this patient group35. With respect to this, absence of the protective 
layer of myocardium surrounding the PVs may be responsible for the enhanced 
susceptibility of the PV wall in response to internal or environmental influences, thus 
making it prone to stenosis. The interaction between the lack of PV myocardial layer 
and the development of PV stenosis requires further investigation.
In conclusion, in hearts with TAPVC no vessel wall was found in the smooth-walled 
LA body and its myocardial layer was structurally abnormal, demonstrating marked 




































myocardium may prevent the onset of arrhythmias in the PVs but may enhance 
PV stenosis. Based on our findings in PAPVC and situs inversus, we hypothesize 
that recruitment of cells, for addition of myocardium and smooth muscle cells at 
the venous pole, mainly takes place from the morphological left side. An open 
connection to the LA is mandatory for proper development of the LA vascular wall 
and myocardium and the pulmonary venous muscular sleeve. The posterior heart 
field is suggested to be responsible for the abnormal myocardialization and smooth 
muscle cell formation of the LA dorsal wall and PVs in TAPVC hearts. This knowledge 
about the PV and atrial morphology in TAPVC hearts may help to understand the 
mechanisms related to the high occurrence of primary PV stenosis and PV stenosis 
after surgery for TAPVC.
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Unilateral Pulmonary Vein Stenosis with 
a Contralateral Pulmonary Varix
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A 41-year-old woman was admitted by the pulmonologist in July 2004 because of 
progressive complaints of dyspnea on exertion. There was no remarkable medical 
history except for mild dyspnea existing from about 1996. Physical examination 
revealed no dyspnea at rest, with normal breath sounds. There were no signs of 
cyanosis. Laboratory data demonstrated a normal hematologic profile and there 
was no serologic evidence for a systemic disease. The chest film showed bilateral 
interstitial abnormalities and a blurred left hemidiaphragm (Fig.1). 
Figure 1. Chest film showing bilateral interstitial abnormalities and a left-sided blurry vascular structure 
above the diaphragm. 
Bronchoscopic findings were within normal limits. Pulmonary function tests showed 
mild bronchial obstruction with normal static volumes (Table 1). Ventilation and 
perfusion lung scintigraphy revealed nearly symmetrical ventilation (R 58%, L 42%) 
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Table 1. Preoperative and postoperative pulmonary function
Pre  Op Post Op Predicted 
FEV1 (L)   3.0   3.0     3.0
VC (L)   4.1   3.8     3.6
FEV1/VC 74 78   81
TLCO/VA, % pred. 68 72 100
Forced expiratory volume in 1 second (FEV1) in liters (L); diffusion capacity corrected for alveolar 
volume (TLCO/VA); vital capacity (VC).
Figure 2. Ventilation (a) and perfusion (b) lung scintiscans showing symmetrical ventilation (right 58% , left 
42%) but asymmetrical perfusion to the detriment of the left lung (right 83%, left 17%). Right posterior 
oblique (RPO), left posterior oblique (LPO).
Cardiac auscultation was completely normal. The electrocardiogram showed signs of 
right ventricular overload and transesophageal echocardiography showed turbulent 
flow at the level of the right pulmonary veins (PVs), together with mild mitral valve 
regurgitation. Cardiac catheterisation showed a pulmonary arterial hypertension 
(40/15-28 mm Hg), discrepant high left pulmonary artery wedge pressure (30 mmHg) 
compared to the left ventricular end-diastolic pressure (LVEDP, 14 mmHg) together 
with a high pulmonary vascular resistance (PVR): 9,5 Woodunits (left); 5 Woodunits 





































Cardiac triggered multidetector computed tomography during intravenous contrast 
administration demonstrated bilateral pulmonary arteriovenous malformations most 
pronounced on the left side (Fig.3a,b). Magnetic resonance (MR) angiography was 
performed to clarify flow directions in the arteriovenous malformations, but it left 
the origin of the tortuous PVs unclear. Stenosis of the PVs at the level of the entrance 
in the left atrium (LA) was most pronounced on the right side. A digital substraction 
angiogram of the pulmonary vessels confirmed a much smaller caliber of the left 
pulmonary artery compared to the right, together with a corresponding difference 
in lung perfusion. The left PVs seemed to be aberrant and varicous but not stenotic.
Based on these findings, surgical resection of the stenotic parts of the right PVs 
was suggested without intervention on the left side because of its underdeveloped 
pulmonary vasculature and its aberrant but uninterrupted inflow of the PVs into the 
LA. Besides that, inspection and possible repair of the mitral valve was indicated.
By means of a median sternotomy, both lungs could be inspected. They had an 
abnormally pale appearance with multiple small vessel injections, more pronounced 
on the left side, so that a lingular as well as a middle lobe biopsy was done. 
Intrapericardially, the right superior and inferior PVs were macroscopically stenotic at 
the entrance to the LA. On the left side, a small vein resembling a left superior caval 
vein was seen together with a vein to the lower lobe. The origin and course of these 
veins were not visible. By inspection inside the right atrium, the possibility of a left 
superior caval vein could be rejected. After atrial septotomy, the entrance of the left-
sided veins in the LA could be passed and appeared not to be stenotic. However, on 
the right side the diameters of the superior and inferior PVs at their entrance into the 
LA were only 4 and 7 mm, respectively. The mitral valve was sufficient and structurally 
normal. Both right PVs were incised longitudinally into the LA. The circumscript 
stenotic parts were resected, which resulted in an increase in diameter to 12 and 
13 mm, respectively. A so-called sutureless pulmonary venoplasty1,2 was performed 
by suturing the LA wall to the pericardium posteriorly and using an autologous 
pericardial patch anteriorly. The postoperative course was uncomplicated. 
The lung biopsies were sent for pathologic analysis in Groningen and the resected 
stenotic parts of the right-sided PVs were analyzed in the Department of Anatomy 
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Figure 3. Multidetector computed tomography. a. Left lateral view and b. Caudal view. A varicous 
pulmonary vein (asterisk) connects to the original pulmonary vein ostium. 
Histological examination of the pulmonary biopsies revealed serious vascular 
pathology with asymmetric and eccentric obliteration of venous as well as arterial 
branches, most pronounced on the left side, to be interpreted as post-thrombotic 
vasculopathy. Thereby, extensive hemosiderosis was seen on the right side. 
Staining of the stenotic rim revealed a large mass of collagen (Fig.4a,b). 
Two weeks after the operation the patient was discharged from the hospital. On 
echocardiography, no turbulence was seen in the right PVs.
After one year’s follow-up, the ventilation-perfusion mismatch between the right 
and left lungs was exactly the same as preoperatively. Exercise capacity, assessed 
by cycle-ergometry, had not improved. Maximal oxygen uptake was 71% predicted 
at a maximal workload of 90 Watts (78% of predicted). Large disturbances in gas 
exchange were shown during the test compatible with large ventilation-perfusion 
mismatch. Also, these findings were comparable with the preoperative situation 
(Table 1). It was decided to be expectative about probable future effects of dead 
space ventilation on the left side. 
High-resolution CT demonstrated non-stenotic veno-atrial transitions on the right 
side (Fig.5). In relation to the right inferior PV, the right superior PV had a smaller 





































Figure 4. Sections of the excised circumferential stenosis of the right superior pulmonary vein stained for 
α-smooth muscle (SM) actin (a), and Resorcin-Fuchsin (RF) (b), showing severe intimal proliferation (I) by 
means of a stenotic rim of collagen without elastic fibers. Lumen (L), media (M), adventitia (A). Scale bars 
are 600µm.
Figure 5. Multidetector computed tomography. Posterior view. The repaired right pulmonary veins 
(asterisks) are nonstenotic. Compared to the right inferior pulmonary vein, the right superior pulmonary 







































PV stenosis is part of the spectrum of abnormal PV drainage. Usually congenital 
in origin, the site of the stenosis depends on the embryologic stage at which it 
develops3,4. The stenosis can also be acquired, called pulmonary veno-occlusive 
disease (PVOD), a condition for which various agents can be responsible5,6. Especially 
in adults, it can be very difficult to determine whether the origin of the anomaly in a 
particular patient is congenital, acquired, or a combination of both7. Extremely rare 
is a PV varix8, which can be associated with a diseased mitral valve9.
When PV stenosis is congenital, two different types can be distinguished10. In the 
first, the so-called hypoplasia of the PVs, narrowing involves the intrapulmonary 
and extrapulmonary part of the PVs for a variable distance. The second type is 
characterized by narrowing at the veno-atrial junction, commonly called localized 
PV stenosis.
In normal development, the embryonic heart is connected to the mediastinum by 
means of the dorsal mesocardium. The major part of this structure regresses, after 
which, at the end of the fifth embryonal week, the lumen of the common PV develops 
in the remaining part of the dorsal mesocardium, and the common PV connects with 
the peripheral PV system11-13. By this point, the lung buds, which drained via the 
splanchnic plexus into the cardinal and umbilical veins, drain directly via the common 
PV into the LA. The connections with the splanchnic plexus and the umbilical and 
cardinal venous system become of less importance and regress. The common PV is 
then incorporated into the posterior LA wall, finally resulting in four individual PVs 
entering the LA. On the left side, also two PVs forming one common PV ostium that 
enters the LA are seen14,15.
If atresia of the common PV occurs very early in development, total anomalous PV 
drainage develops and the embryonic systemic venous connections do not regress but 
establish a supra- or infracardiac drainage unless the PVs drain into the right atrium. If 
stenosis of the common PV occurs later, incorporation is disturbed which may result 
in cor triatriatum3,4. Atresia or stenosis of the left or right common PV leads to partial 
anomalous PV drainage so that the ipsilateral systemic venous drainage persists. If 
stenosis occurs very late, after PV incorporation has been completed, stenosis or 




































partial obstruction of one or more PVs may not be enough to preserve embryologic 
(systemic) venous drainage16,17. After delivery, an increasing amount of blood volume 
reaches the lungs by which the hemodynamic effect of individual PV stenosis can be 
more pronounced. 
If necessary, therapeutic options are percutaneous transluminal balloon angioplasty, 
stenting or surgical resection. 
Acquired PV stenosis or PVOD is characterized by extensive and diffuse occlusion of 
PVs by fibrous tissue. Usually the (eccentric) intimal thickening involves venules and 
small veins but, occasionally, also larger veins and, in later stages, arterioles. The 
media of the veins may become arterialized with an increase in elastic fibers. The 
most consistent early parenchymal change is interstitial edema, which may progress 
to deposition of collagen fibers in the lobular septa and alveolar walls, as often 
observed when histologic features are obtained18. Lymphatic vessels are dilated. A 
more obvious finding, in particular in later stages, is hemosiderosis, found commonly 
in alveolar macrophages or less commonly also in the interstitium. 
Clinically, cases present with pulmonary arterial hypertension without elevation 
of the pulmonary arterial wedge pressure7,18. Many agents may be responsible for 
the etiology of PVOD. Infectious, genetic, and toxic factors have been described as 
well as a thrombotic diathesis and autoimmune disorders18. Because PVOD is a rare 
condition, no randomized therapeutic trials have been undertaken to compare the 
effect of current treatment modalities, that is, vasodilators, immunosuppressives, 
anticoagulants and oxygen, on outcome. Because the prognosis is usually bad within 
2 years after diagnosis, lung transplantation seems the only option for significantly 
prolonging life expectancy.
A PV varix is also a very uncommon anomaly that can be congenital or acquired. 
The congenital form usually is asymptomatic. The acquired form develops as a result 
of obstructed PV drainage and presents with symptoms of the underlying disease 
causing PV hypertension, for instance mitral valve disease or PV stenosis. Treatment 
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In our patient, the etiology of the right-sided focal PV stenosis at the veno-
atrial junction is likely to be congenital in origin in view of the combination with 
a diseased (nonfunctional) left lung. Acquired central PV stenosis in combination 
with a nonfunctional left lung would be very unlikely because in hemodynamically 
comparable situations of normal PVs in patients who have had pneumonectomy, 
subsequent development of contralateral pinpoint central PV stenosis is very 
uncommon. However, an additional acquired component in this region must have 
been responsible for the progression of the dyspnea; the function of the left lung 
decreased and flow to the right lung subsequently increased, thereby inducing 
intimal proliferation at the right veno-atrial junction to a critical point by means 
of altered flow profiles as turbulence19. Nonetheless, the significant ipsilateral 
hemosiderosis with moderate obliteration of small veins and arteries in the biopsy 
specimen, together with a normal right-sided pulmonary arterial wedge pressure, 
suggests a possible superposed PVOD. On the left side, the small caliber pulmonary 
artery, the elevated pulmonary artery wedge pressure, and the decreased perfusion 
of the left lung because of a very high PVR in combination with histologic fibrotic 
changes mimicking micro-infarction suggests left-sided PV atresia. Considering the 
two apparently normal left PV ostia entering the LA and the nonhypoplastic left lung, 
this atresia must have been developed during the late fetal period. After this, and 
under pressure, the varicous vein must have developed and connected with both 
left PVs, after which left-sided PV drainage was delayed but uninterrupted. If we 
deal in this case with some degree of PVOD in the right lung, careful follow-up is 
necessary because of its aggressive behaviour. Now the venous flow of the right lung 
to the LA is unobstructed, theoretically, dead space ventilation on the left side will 
increase. So long as this patient is doing well, an expectant policy is warranted. Thus 
for ethical reasons, we have not yet performed a postoperative recatheterization. If 
her situation deteriorates, cardiac recatheterization should be performed. In case 
of increased dead space ventilation on the left side, combined with acceptable PA 
pressures and PVRs on the right, a left pneumonectomy would be an option. In case 
of an irreversible increased right-sided PVR and a very bad clinical condition, this 




































In conclusion, differentiation between congenital or acquired stenosis of PVs or a 
combination of both can be very difficult. However, cardiac catheterization and a 
lung biopsy can bring more clarity. This is necessary inasmuch as the acquired form 
behaves more aggressively than the congenital version and needs a closer follow-up 
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Interest for the pulmonary veins has increased in the past decade after the 
potential arrhythmogenicity of the myocardial sleeve surrounding these 
structures has been recognized. Furthermore, there are several clinical 
entities, such as anomalous connection pattern and pulmonary vein stenosis, 
that are related to abnormal pulmonary vein development. 
In this review, we will describe current literature and aim to elucidate and 
reorganize current opinions on normal and abnormal pulmonary vein 
development in relation to clinical (management of) diseases. Several 
unresolved questions will be addressed, as well as current conceptual 
controversies. First, a general overview of development of structures at the 
venous pole of the heart, including normal development of the pulmonary 
vein from a primitive Anlage, will be provided. Recent insights indicate an 
important contributory role of the mesoderm behind the heart, the so-called 
second heart field, to this area. Subsequently, the formation of a myocardial 
and smooth muscle vascular wall of the pulmonary veins and the left atrium 
is described, as well as current insights in the mechanisms involved in the 
differentiation of these different cell types in this area. Next, developmental 
concepts of normal pulmonary venous drainage patterns are reviewed, and 
an overview is provided of clinical entities related to abnormal development 
at several anatomical levels. Lastly, attention is paid to arrhythmogenesis in 








































In recent years, the involvement of the pulmonary veins (PVs) in several pathogenetic 
processes, has increasingly been recognized. The PVs play a role in the onset of atrial 
arrhythmias, such as atrial fibrillation1. Furthermore, congenital malformations, 
including abnormal pulmonary venous drainage patterns and PV stenosis, may 
warrant surgical or percutaneous interventions. Also the structure of specific 
components of the PVs may be involved in pathogenesis, e.g. vulnerability of the 
smooth muscle and myocardial wall for acquired PV stenosis.
In the light of these clinical considerations, understanding of both normal and 
abnormal PV development is mandatory. PV development is narrowly related 
to development of the venous pole of the heart, that includes the sinus venosus 
and atrial segment. Recent new insights have demonstrated that during cardiac 
development large compartments of the heart are developed in and subsequently 
incorporated from the mesocardium behind the heart, the so-called second heart 
field2,3. 
Current concepts of PV development result in several questions that seem to 
recirculate and ask for clarification. We should in this regard also take notice of the 
fact that differences in semantics, definitions and interpretations of findings might be 
of great influence. After giving a general overview of development, in this review we 
will focus on the following questions:
1. How are the different components of the venous pole defined and what are 
current controversies? 
2. Which role does the second heart field play in the development of the venous 
pole, myocardialization and smooth muscle cell (SMC) formation of the PVs?
3. What, in the view of previous points, are the current developmental concepts on 
the origin of normal and abnormal PV connection? 
4. How is PV development related to arrhythmogenesis?





































We will try to clarify these topics by describing normal and abnormal PV development, 
as well as the relation to clinical entities, based on our own research and current 
literature. 
With regard to abnormal PV development, in literature different terms are used 
to describe the same condition. While “anomalous PV drainage or return” mainly 
focuses on the physiological condition, “anomalous PV connection”, in our opinion, 
describes most accurately the anatomic condition.
General overview of early cardiac development.
The embryo starts as an embryonic plate, in which a primitive streak area develops4. 
The primitive streak is formed as an invagination in the midline of the embryonic 
plate, at the initiation of gastrulation (the formation of the three embryonic germ 
layers). From the primitive streak, two large lateral plate mesodermal compartments 
are derived on both sides of the embryonic axis4 (Fig.1a, upper panel). In each 
compartment a coelomic cavity develops that splits the mesoderm into a somatic 
layer, lining the ectoderm, and a splanchnic layer, lining the endoderm5. The 
bilateral splanchnic mesoderm contains the cardiac precursor cells. Anterior to 
the embryonic axis (notochord), these mesodermal compartments fuse to form 
a primitive myocardial heart tube (primary heart tube) that is lined on the inside 
with endocardium and separated from the myocardial layer by cardiac jelly4,5. After 
a complicated bending of the head region of the embryo, this heart tube obtains an 
arterial (anterior/cranial) pole and a venous (posterior/caudal) pole (Fig.1a, lower 
panel).
During further development of the heart, splanchnic mesodermal cells from the 
so-called second heart field will continue to be added to the heart2,3. The second 
heart field is defined as an anteroposterior extension of mesoderm, located behind 
the heart, from which myocardium is incorporated to the heart during further 
development. The contribution to the venous pole of the heart is referred to as 
derived from the posterior heart field6,7, whereas the contribution at the arterial pole 
is referred to as derived from the anterior or secondary heart field8,9 (Fig.1b-d). The 
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The splanchnic mesoderm also differentiates into a vascular plexus of endothelial 
cells. This plexus is the source of the lining of the vitelline veins, the pharyngeal arch 
arteries and the initially bilateral dorsal aortae4,5. The splanchnic plexus is connected 
to the sinus venosus, being itself in connection with the common atrium, by means 
of a small strand of endothelial cells, the so-called midpharyngeal endothelial strand, 
which runs from the arterial to the venous pole of the heart10. This structure is the 
Anlage of the primitive PV (see section 3), that is situated in the mesocardium behind 
the heart (the dorsal mesocardium). We will focus on structures that will develop at 
the venous pole of the heart, being the area in which the PV develops.
1. How are the different components of the venous pole defined?
The inflow part or venous pole of the heart includes the embryological sinus 
venosus segment and the atrial segment. These compartments constitute the most 
caudal parts of the primary heart tube (Fig.1a). In this paragraph we will clarify the 
nomenclature of embryological structures at this site, as well as their counterparts in 
the adult. As will become clear, definitions and descriptions of some structures have 
been the subject of vivid discussions over the past decades. We will also address 
these controversies where appropriate.
After development from the second heart field (see section 2), the sinus venosus is 
connected to the common atrium and consists during the 4th week of development 
of a left and right part, each receiving blood from the vitelline/omphalomesenteric 
vein, the umbilical vein and the common cardinal vein. During early stages of 
development, the border between the sinus venosus and the still unseptated 
common atrium, can be distinguished as a fold of myocardium, the sino-atrial fold. 
Asymmetrical growth of the right part of the common atrium causes a rightward shift 
of the site of connection of the sinus venosus to the common atrium. The right part 
of the sinus venosus and corresponding veins also enlarge and form the caval veins 
that are incorporated into the future right atrium. The left part of the sinus venosus 
obliterates to a large extent in human development. The left common cardinal vein 
will form the coronary sinus. In mice, the left anterior cardinal vein (the cranial 
branch of the common cardinal vein) will persist as the left superior caval vein, while 




































(oblique vein of Marshall in case of incomplete obliteration). After septation, the 
right atrium consists of 2 parts: the smooth-walled main body derived from the sinus 
venosus and the right trabeculated atrial appendage. The sinus venosus part of the 
right atrium, receiving the caval veins and the coronary sinus (in the adult called 
sinus venarum) contains during development 2 muscular valves: the right and left 
venous valves. The inferior part of the right venous valve will form in the mature 
heart both the Eustachian valve, covering the inferior caval vein, and the Thebesian 
valve, covering the coronary sinus. The left venous valve in human fetuses fuses 
with the atrial septum that develops at the end of the 4th week11, whereas in mice 
it can still be distinguished as a separate structure. The superior part of the right 
venous valve will develop into the terminal crest (or crista terminalis), that forms 
a border structure between the right atrial appendage and the right atrial body or 
sinus venarum in the adult.
Between the 4th and 5th week of development a lumenized PV can be discriminated in 
the dorsal mesocardium, derived from the midpharyngeal endothelial strand10. The 
PV is at this stage a single structure, that is, at the entrance into the sinus venosus 
(connecting to the common atrium), bordered by 2 muscular ridges, the left and 
right pulmonary ridges. These ridges are part of the so-called dorsal mesenchymal 
protrusion (DMP)12,13, an accumulation of mesenchymal cells that encompasses the 
primitive PV, and that contributes to the atrial septum14. During atrial septation, the 
DMP is responsible for the shift of the PV towards the left side13. Thus, after atrial 
septation, the common PV drains to that part of the sinus venosus that is incorporated 
in the posterior wall of the left atrium (LA) after which the right pulmonary ridge 
fuses with the left side of the atrial septum14. Subsequently, the PV bifurcates, dilates 
and incorporates into the LA, contributing to the size and consistency of the smooth-
walled LA body, which has histological identical characteristics to the PV, with an 
inner vascular layer covered on the outside by myocardium15. Usually, by the end of 
this process, two right and two left PVs enter the LA, although variations in anatomy 
are very common16. Similar to the situation on the right side, the trabeculated LA 
appendage can be distinguished from the smooth-walled LA body. Histologically, a 
transitional zone between these parts can be recognized that is similar to the sinus 







































Schematic representation of sequential stages of cardiac development and the contribution from first 
and second heart field. The primary heart tube is depicted in brown and the myocardium that is derived 
from the second heart field (and incorporated later in the heart) in yellow. A. The primary heart tube is 
formed after fusion of bilateral plates of splanchnic mesoderm in the primitive plate. This tube already 
has a venous pole (VP), and an arterial pole (AP). B. Lateral view of embryo (approximately 23 days in 
human), showing the primary heart tube, surrounded by cardiac jelly (blue), and the second heart field 
situated dorsally to the heart. C. Human embryo at 25 days. The primary heart tube has expanded both 
at the venous and at the arterial pole with myocardium derived from the second heart field (depicted in 
yellow). D. Scheme of the nomenclature the primary and second heart field (see also Chapter 1, Fig.1). At 
the venous pole of the heart, myocardium is derived from the posterior heart field, that contributes to the 
posterior wall of the atria and the interatrial septum, the sino-atrial node (SAN), the myocardium of the 
sinus venosus (SV), pulmonary veins (PV) and cardinal veins (CV) including the coronary sinus, part of the 
central conduction system (CCS) and the dorsal mesenchymal protrusion (DMP). The second heart field 
contribution to the venous pole is discussed in more detail later on in this review. Modified after: Crawford 
and DiMarco, third edition 2009125.
1.1 Current controversies regarding definitions  
1.1.1. Drainage of the primitive PV to the sinus venosus or to the LA segment? 
The question whether the common PV originally is connected to the sinus venosus 
segment or to the LA segment has been a topic of vivid discussion over the past 
decades. In literature there have been advocates of an original connection of the 




































these divergent opinions in the past might be the absence of adequate techniques 
for a distinct demarcation of the sino-atrial fold in the region of the PV, making it 
difficult to decide whether the PV connected to a sinus venosus or LA structure. 
Other limitations were the lack of availability of human embryos in good condition, 
(resulting in some cases in incorrect interpretations25 that were revised later on30) 
and the comparability of stages between different species. Although recent studies 
using novel molecular techniques have contributed new data, this discussion is still 
alive and seems at least partly to be based on different interpretations of similar 
findings.
On the basis of scanning electron microscopic studies it was reported by some 
authors that the PV is connected to the LA, cranial to the systemic venous tributaries 
at gestational day 10 and 11 in mouse27, at HH 15-30 in chick28 and at Carnegie stage 
12 in human embryos29. In these studies, the sinus venosus segment was defined as 
the part of the atrium that was encompassed by the venous valves. Indeed, when 
the left and right venous valves are taken as border structures for the sinus venosus, 
then the PV does not drain in this area. A limitation of this definition is however, 
that in very early stages, venous valves can not be distinguished yet. Furthermore, 
on the basis of expression of the myocardial markers Cx40 and ANF, in combination 
with 3-dimensional reconstructions, it has been concluded that the venous valves 
themselves are not completely part of the sinus venosus26. According to these 
studies, from the outset, the myocardium surrounding the PV is distinct from that 
lining the systemic veno-atrial junctions based on expression patterns of molecular 
markers26,31. It should be noted however in this regard, that, there is no evidence that 
the PV is surrounded by myocardium from the outset, as it has been demonstrated 
that the PV myocardial sleeve only develops from stage E11.5 and further on32-34. 
In contrast to these studies, other studies propagate an original connection of the 
primitive PV to the sinus venosus segment of the heart. In the mouse, at day 9.5 
(Carnegie stages 11-12), the primitive PV was recognized posterior to the sino-atrial 
fold, its endothelium being continuous with that of the sinus venosus22. Also in 
quail embryos, from stage HH15 onwards, expression patterns of the marker HNK-
1, which is expressed in the sinus venosus myocardium, suggested that the orifice 
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HNK-1 expression of the embryonic myocardium surrounding the PV was also 
seen in rat (E 13.5)23 and human (CRL14-23mm)35 embryos. Consistent with these 
findings are more recent data published by our group on CCS-LacZ expression32 
and expression of podoplanin in the developing myocardium surrounding the PVs 
in mice6. The marker CCS-LacZ is expressed in the myocardium surrounding the PV, 
that becomes continuous with the CCS-LacZ positive sinus venosus area of the right 
atrium. The posterior heart field marker podoplanin is expressed in major parts of 
the cardiac conduction system and also found in the myocardium surrounding the 
PV. It’s expression is linked to the Nkx2.5 negative sinus venosus myocardium of the 
posterior heart field6,36 (see section 2).
Based on the results of our studies, we favour an original connection of the primitive 
PV to the sinus venosus segment of the heart. 
Figure 2.
a. Transverse section through the sinus venosus and left and right atrial appendage of a chick embryo 
(HH17).
b. Electron microscopic picture at the same level. Arrows point at the sino-atrial fold, which separates the 
sinus venosus from the atrial segment. The asterisk indicates the common pulmonary vein, that appears to 
drain in the sinus venosus. Atrio-ventricular canal (AV), left atrial appendage (LAA), right atrial appendage 




































1.1.2. Is there a direction of growth of the primitive PV in relation to the heart?   
Already since the middle of the nineteenth century there have been different opinions 
about the direction of growth of the PV in relation to the heart, in other words: does 
the primitive PV grow out from the heart towards the lungs, or vice versa? In former 
reports by Buell in chick17, Schornstein in pig37, Auër in rat and rabbit embryos38, and 
Los in human embryos25, the stem of the PV was considered to be an outgrowth of 
the dorsal wall of the atrium, whereas by Brown in domestic cats39, and by Davies 
in a human neonate40, the primordium of the PV was considered to grow out of the 
splanchnic plexus of veins towards the heart. The splanchnic plexus is not species-
specific17,39,41. In quail embryos, this vascular plexus arises at HH8 by differentiation 
of splanchnic mesodermal cells into endothelial precursor cells (vasculogenesis). The 
midpart of this splanchnic plexus is the earlier mentioned midpharyngeal endothelial 
strand. Immunohistochemical studies performed in avian embryos, using antibodies 
against quail endothelial cells and precursors, showed that this midpharyngeal 
endothelial strand from early stages on connects the endocardium of the primitive 
heart tube to the splanchnic vascular plexus around the foregut and the lung buds 
and contains the Anlage of the non-lumenized common PV10. This is supported by 
studies in mouse, chick and human embryos by Webb et al.27-29. This implies that, in 
contrast to the concepts of PV ingrowth39,40 and outgrowth17,25,37-39, the endothelium 
of the PVs has been connected to the endocardium of the heart right from the 
beginning10,18. 
2. Which role does the second heart field play in the development of the venous 
pole? 
As mentioned earlier, there is increasing attention for the role of the second heart field 
in cardiac development. Different lineage markers have been used to study the final 
destination of cells in the heart2,7,42-44. Islet (Isl)1 is a marker for cells recruited from 
the second heart field and is expressed at the arterial as well as the venous pole of 
the heart during differentiation2 (Fig.1d). There are several markers expressed in the 
posterior heart field, including, Shox245, Tbx1842, Pitx246, podoplanin6,7, but excluding 
(lack of expression of) Nkx2.56,46. The posterior heart field, as a part of the second 
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atrial septum6,7 (Fig.1d). A subset of cardiac progenitor cells in the posterior heart 
field receives Hedgehog (Hh) signals, likely from pulmonary endoderm, resulting 
in migration of these progenitor cells through the dorsal mesocardium to form the 
atrial septum as well as the DMP47. Similar to Hh signaling, also, PDGF-signaling is 
known to play a role in the development of second heart field derived structures of 
the venous pole48.
Next to a contribution to these aforementioned structures, in recent years, second 
heart field contribution to the vascular wall and myocardium surrounding the PVs36,49 
has been established.
2.1 Second heart field contribution to formation of a PV myocardial sleeve.
Several theories exist about the origin of the myocardium surrounding the PVs. The 
three most important processes described are: First the process of myocardialization 
which refers to migration of atrial cardiomyocytes into the extracardiac mesenchyme 
and extending towards the PV34,50-52. Between species, differences exist in the 
extension of the myocardial sleeve. In mice, this sleeve extends intrapulmonary49,53, 
while in the chick this intrapulmonary (i.e.peripheral) myocardial extension is very 
limited54. The second process is recruitment, which refers to differentiation of 
splanchnic mesenchymal cells into cardiomyocytes6,33,55,56 and the third process is a 
combination of the two aforementioned46. The recruitment of mesenchymal cells fits 
smoothly with earlier research in cardiac development underlining the addition of 
myocardium to the primary heart tube57, from the second heart field2,3.
In the context of the origin of myocardium surrounding the PV, as aforementioned, 
the myocardial markers Nkx2.56,46, Pitx246, Shox245, Tbx1842 and podoplanin6,7 are 
of interest for their expression in cells that contribute to the venous pole of the 
heart. Here, a distinction must be made between the mesoderm that surrounds the 
primitive PV in early stages (when formation of a myocardial sleeve around the PV has 
not taken place yet), and that is Nkx2.5 positive already in early stages; and the newly 
added myocardial sleeve that develops around the PV at stage 12.5 and further on32-34. 
Nkx2.5 expression in this newly forming myocardium around the PV initially is absent 
during a brief time period6 (like in the sinus venosus myocardium), rapidly turns into 




































positive, indicating newly added myocardium that has differentiated. Compared 
to the cardinal veins that become Nkx2.5 positive at a later stage as well, this was 
considered as the result of a higher proliferation rate of myocardium of the PVs7,49, 
which is in line with previous findings by other groups of a high proliferation rate of 
the PV myocardium as compared to the proliferation rate of the atrial myocardium46.
Several markers expressed in putative PV myocardium, including the myocardial 
marker MLC2a and the posterior heart field marker podoplanin6, are initially 
expressed at the left side of the dorsal mesocardium, indicating that PV myocardium 
is preferentially added from the left side of the posterior heart field, regulated by 
progenitor cells that play a role in left-right patterning, as was reported for Pitx2c46,58,59. 
Podoplanin is a transmembrane protein that was originally described in the kidney 
and in later studies was found to be expressed in the heart. Podoplanin knockout 
embryos show marked hypoplasia of the posterior heart field derived myocardium 
of the sinus venosus, including the sinus node and the myocardium surrounding the 
PVs and covering the posterior atrial wall36. Interestingly, in this model also a reduced 
number of SMCs was observed, indicating that the posterior heart field has a role 
in myocardial and SMC contribution at the venous pole of the heart36,49. This will be 
further addressed in section 2.2. Analogous to podoplanin mutants, chick, mouse and 
human embryos with DMP abnormalities caused by defective Hh or PGDF-signaling, 
also show hypoplastic PV myocardium, indicating a role of the DMP in proper PV 
development48.
2.2 Second heart field contribution to smooth muscle cell (SMC) formation in the PVs 
and LA.
SMCs are another important source of cells that contribute to the vascular layer of the 
PVs and the inner layer of the LA15. It has been described that SMCs can differentiate 
from mesenchymal cells60. At the arterial pole SMCs have been described to originate 
from the splanchnic mesoderm, the neural crest61 or endothelial cells62. At the venous 
pole however, not much is known about the origin of SMCs. As was implied above, 
several hypotheses consist about the origin of the SMCs in the LA body. Initially, SMCs 
were considered to migrate from the PVs towards the heart and into the LA34. SMCs 
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LA15. The above mentioned data60-62 have suggested differentiation as a mechanism 
by which the presence of SMCs in the LA can be explained, which has been supported 
by studies using the posterior heart field marker podoplanin49. In podoplanin knock-
out embryos there is a significantly reduced myocardial cuff around the PVs as 
well as a reduced number of SMCs. Similar findings were reported by Bleyl et al. 
in embryos with DMP abnormalities48. These SMCs do not extend in the complete 
smooth-walled LA body. These findings indicate that a process of differentiation 
rather than incorporation is the mechanism responsible for SMC formation in the 
LA (Fig.3; compare with Chapter 1, Fig.2, adapted to new insights). These findings 
are in line with observations that have been made in the inhibitor of differentiation 
(Id2) mouse model. Id2 knockout mice seem to have small-sized LA bodies -probably 
caused by impaired or delayed PV incorporation-, while the amount of differentiated 
smooth muscle cells in the LA did not differ from wild type mice (Jongbloed et al., 
unpublished results). 
These data suggest that incorporation and differentiation are two autonomous 
independent processes. 
3. What are the current concepts on the origin of normal and abnormal PV drainage?
In the paragraphs above, we have described the origin of the PV Anlage from 
the midpharyngeal endothelial strand, that is connected to the heart from the 
beginning. During development different drainage patterns of the primitive PV can 
be distinguished (Fig.3a-g). We will describe here the drainage patterns according 
to Rammos30, who discriminated three periods with different drainage patterns in 
normal human PV development: 1. A peripheral period (CRL 4.4-7mm) during which 
there is no open connection yet between the primitive atrium and the developing 
lung vessels. The mid-pharyngeal endothelial strand has not lumenized yet. The 
primitive lung drains via the splanchnic venous plexus into the systemic venous 
circulation (cardinal and umbilical veins). 2. An intermediate period (CRL 7-11mm) 
during which the lumenized common PV connects to the LA as well as to the lung 
plexus. The lungs can drain their blood either centrally to the LA, or peripherally 
to the systemic venous system. 3. A central period during which the only possible 
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Figure 3a-g. Schematic depiction of pulmonary vein development, adapted to new insights.
a,b. Peripheral period, lateral (a) and frontal (b) view. The splanchnic vascular network surrounds the 
two lung buds (LB) and drains to the systemic circulation by means of primitive pulmonary-to- systemic 
connections to the right and left cardinal veins (RCV/LCV) or the right and left umbilical and vitelline veins 
(RUVV/LUVV). In the region of the heart, this splanchnic plexus (SP) is connected to the sinus venosus 
segment of the heart (SV, blue) by means of the midpharyngeal endothelial strand (MPES), which is the 
remaining part of a strand of endothelial cells that initially runs from the arterial to the venous pole in the 
dorsal mesocardium.
c. Intermediate period. When the endothelial strand, which is the anlage of the future common pulmonary 
vein (CPV) lumenizes, the splanchnic plexus can drain its blood to the systemic circulation as well as to 
the heart. Although atrial septation has started, the CPV still drains to the sinus venosus segment that is 
connected to a common atrium.
 d. Central period. The CPV grows and dilates, becoming the main route for drainage of pulmonary venous 
blood. The primitive pulmonary-to-systemic connections are not necessary anymore and regress. After 
atrial septation has completed (IAS), the part of the sinus venosus containing the CPV is placed to the left, 
becoming part of the left atrium (LA).
e. The CPV has bifurcated, so that the right and left lung (RL/LL) drain to the heart by means of two left 
and two right pulmonary veins. The right cardinal vein becomes the superior caval vein (SCV) and the left 
cardinal vein gives rise to the coronary sinus (CS), both connecting to the sinus venosus part of the right 
atrium (RA).
 f,g. By incorporation of the CPV, initially, one right and one left CPV drain to the LA (f). After incorporation 
has completed, four separate pulmonary vein (PV) ostia can be identified on the inner side of the LA (g). 
Independent on PV incorporation, smooth muscle cells (red) can be identified in the LA as a result of 












































































a. 3-D Reconstruction of the thoracic contents of a normal human embryo of 18 mm crown-rump length 
(approximate gestational age 8 weeks; Carnegie stage 14). Frontal view, after resection of the heart 
including part of the left atrial dorsal  wall. Four pulmonary veins (arrows) are connected to the lung 
region and to a short common pulmonary vein that has an open connection with the left atrial (LA) dorsal 
wall. At this stage there is no connection anymore of the splanchnic plexus (SVP) to the lungs, but still 
very small communications of the SVP with the right (RCV) and left cardinal veins (LCV) exist caudal to 
the innominate vein (InV). Aorta (Ao), descending aorta (DAo), ductus arteriosus (DA), esophagus (E), 
trachea (T).
b. 3-D Reconstruction of an abnormal human embryo of 18mm crown-rump length (approximate 
gestational age 8 weeks; Carnegie stage 14). Frontal view, after resection of the heart, including part of 
the left atrial dorsal wall. Posteriorly to the left atrial (LA) dorsal wall three individual pulmonary veins, 
originating from a common pulmonary vein run towards the lungs. On the left side the left upper PV is 
lacking (open arrow), the left lower PV does not contain blood (black arrowhead). The two right PVs (black 
arrows) are normal. The splanchnic vessels (SVP) extend a great deal further than in the normal embryo 
and with numerous connections to both lungs. A large communication analogous to the vertical vein (C) 
exists between the splanchnic plexus and the left cardinal vein (LCV). Aorta (Ao), ductus arteriosus (DA), 
esophagus (E), innominate vein (InV), right cardinal vein (RCV), trachea (T).
The primitive connections of the lung to the systemic veins are not necessary 
anymore at this stage and regress30,63 by a process called remodeling, analogous to the 
developmental processes at the arterial pole64. Persistence of pulmonary-to-systemic 
communications is the likely substrate of extracardiac anomalous PV connections, 
probably related to abnormal development of the common PV (TAPVC) or one of its 
branches (PAPVC)30,63,65. On the other hand, cardiac anomalous PV connections seem 
to result from absent or impaired mesenchymal contribution to atrial septation14,48.
Insights in abnormal PV development historically have mainly been based on post-
mortem studies leading to classifications and tentative embryological explanations 
of the encountered anomalies63,66. Total anomalous PV connection was explained by 
a shift of the common PV with regard to the atrial septum, leading to a complete 
connection to the right atrium, or, when the PV connection with the atrium was lost, 




































Abnormal PV development can be based on various processes that take place 
at different developmental stages and at different anatomical levels. These are 
summarized in Table 1. These processes lead to different congenital heart anomalies 
(clinical entities), that we will subsequently describe in relation to embryonic 
development. 
Noteworthy is that, regularly, inflow and outflow tract abnormalities are found to co-
exist67,68. Since the second heart field contributes to incorporation of mesenchymal 
cells at both the venous as well as the arterial pole of the heart2, second heart field 
impairment may be the underlying cause for this co-existence.
3.1. Clinical entities (also see Table 1).
3.1.1 Total anomalous pulmonary venous connection (TAPVC). 
In this condition there is no open connection to the LA because of non-lumenization of 
the midpharyngeal endothelial strand (PV Anlage) or atresia of an initially lumenized 
common PV. If the latter takes place at a late embryonic stage, the condition is 
lethal, with 4 PVs draining to a blind ending confluence (Table 1). Usually, all the 
PVs drain to the systemic venous circulation (extracardially), but rarely, they have 
a cardiac connection as a consequence of impaired mesenchymal contribution to 
atrial septation14,48. Four types of TAPVC can be discriminated: A supracardiac type 
accounting for 45% of cases; an infracardiac type for 25%; a cardiac type for 25%; 
and a mixed type for 5%69. 
The supra- and infracardiac type both belong to the extracardiac group of TAPVC which 
means that, in absence of an open connection to the LA, the nearest extracardiac 
systemic vein is used for PV drainage. The preserved primitive pulmonary-to-
systemic connection is represented by the so-called vertical vein. In supracardiac 
TAPVC the (left) vertical vein usually connects to the innominate (brachiocephalic) 
vein, less often to the superior caval vein -at the cavo-atrial junction-, and rarely 
to the azygos vein. These systemic veins are representatives of the peripheral part 
of the former cardinal veins. The commonest sites of connection in patients with 
infracardiac TAPVC are the portal vein (65%) and the embryonic ductus venosus, 
that has persisted in these patients. Less common are connections to the gastric vein, 
the hepatic veins and the inferior caval vein. These systemic veins originate from the 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the cardiac type of TAPVC, the PV confluence drains directly to the right atrium, 
or more often, directly to the coronary sinus. Drainage to the coronary sinus is 
the result of persistence of pulmonary-to-systemic venous connections to the left 
common cardinal vein (which becomes the coronary sinus). The etiology of the direct 
connection to the right(-sided) atrium is a topic of discussion since this condition is 
very rare in case of situs solitus (i.e. in normal atrial arrangement), and almost always 
associated with (right) atrial isomerism70. Leftward displacement of the atrial septum 
has been proposed71, although this was also considered a secondary phenomenon to 
the abnormal expansion of the developing right atrium due to incorporation of the 
PVs72. The fact that this condition is more often seen in case of right atrial isomerism 
suggests that inhibition of left-sided structures is a more probable explanation. 
This would fit in the concept of a bilateral Anlage (left and right pulmonary pit) 
with development of the right pulmonary pit and inhibition of the left part as was 
suggested by Männer72. Such a bilateral Anlage was never identified by our group. We 
hypothesize that in case of right atrial isomerism, the unilateral Anlage or common 
PV connects to one of the “right” atria or maintains a midline position, connecting 
to both atria, since atrial septation is also disturbed in this condition73. Another 
component that might play a role in the onset of cardiac TAPVC to the right atrium 
is the dorsal mesenchymal protrusion, which role in atrial septation and leftward 
displacement of the PV has already been established12,13. Defective development 
of this dorsal mesenchymal protrusion might lead to a rightward shift of the PV, 
resulting in PV drainage to the sinus venosus part of the right atrium14,48.
The mixed type usually is a combination of the cardiac and supracardiac type of 
TAPVC, in which the left PVs drain to a vertical vein and the right PVs to the coronary 
sinus, as already explained. Also this type finds its origin in an absent or atretic PV 
Anlage.
3.1.1.1. TAPVC and immunohistochemical findings.   
On the basis of comparative immunohistochemical studies of the LA dorsal wall and 
the PVs between normal human hearts and hearts with TAPVC, we know that, in 
contrast to normal hearts, in hearts with TAPVC a. PVs have no myocardial sleeve 
b. the LA has no inner smooth muscle cell layer and c. the LA body is very small and 
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a.: Lack of a PV myocardial sleeve in TAPVC. It is noteworthy that in this condition, 
also the vertical vein, i.e. the persisted pulmonary-to-systemic connection, lacks 
myocardial covering. In both normal hearts and hearts with situs inversus, the PVs 
are normally myocardialized which means that myocardialization is not dependent on 
left-sidedness in the body but probably on left second heart field signaling. In hearts 
with partial anomalous pulmonary venous connection (PAPVC), only the normally 
connecting PVs are myocardialized, from which we hypothesized that a connection 
of a PV to the LA is necessary for myocardialization to occur67 (Fig.5).
The fact that left-right patterning seems to play a role in myocardialization of the 
PVs is supported by studies using the differentiation marker Pitx246,58,59,74-76. Pitx2 
is a homeodomain transcriptional protein, which Pitx2c isoform is exclusively 
expressed in the heart, driving asymmetrical cardiac morphogenesis. Initially, Pitx2c 
is asymmetrically expressed in the left lateral plate mesoderm and subsequently in 
the cardiogenic precursors of the left second heart field, supplying both the venous46 
and the arterial pole77. At the venous pole, Pitx2c is present in the posterior heart 
field in mesenchymal cells, that will later on differentiate into myocardial cells. PVs 
of Pitx2c mutants have no myocardial sleeve46. Pitx2 represses the transcriptional 
pathway of right atrial identity, also suppressing the SA node transcriptional program 
on the left side75. So, Pitx2c mutants show right atrial isomerism46. Since both Pitx2c 
mutants and TAPVC patients lack a PV myocardial sleeve, there might be a connection 
between Pitx2c and TAPVC. This possibility is supported by the fact that right atrial 
isomerism as well as TAPVC frequently go together with asplenia78. Until now, a 
relation between Pitx2c and asplenia, was not reported in literature.
b.: Lack of LA inner smooth muscle cell layer in TAPVC. As mentioned above, 
differentiation rather than incorporation is the mechanism responsible for SMC 
formation in the LA49. The podoplanin knockout mouse model, shows an impaired 
formation of SMCs in the LA body, similar to human TAPVC67, suggesting that lack of 
a SMC layer in TAPVC is also based on a differentiation impairment.
c.: Small LA size. The small size of the LA in TAPVC is the consequence of non-
incorporation of the PVs. In fact, the LA body has not fully developed and the main 
part of the LA is formed by the LA appendage. Additionally, reduced hemodynamic 




































Non-compact, hypoplastic LA myocardium in TAPVC. Impaired formation and 
differentiation of posterior heart field derived myocardial and smooth muscle cells 
in the PVs and the LA dorsal wall are findings both observed in knockout models of 
PHF markers and in TAPVC, suggesting that impairment in the posterior heart field 
contributes to TAPVC.  A developmental explanation for the spongious LA myocardium 
in TAPVC may be the impaired formation of epicardium derived cells (EPDC’s) and 
altered epicardial-myocardial interaction, which are known to be responsible for 







































Schematic depiction of outer (a,c,e,g,i) and inner (b,d,f,h,j) side of the atrial chambers and the pulmonary 
veins (PV) in normal hearts (a,b), hearts with total anomalous pulmonary venous connection (TAPVC;c,d), 
hearts with (extra)cardiac partial anomalous pulmonary venous connection (PAPVC; e-h) and hearts with 
situs inversus (i,j).
a,b. Normal heart. a. The left atrial body (LAB) and pulmonary veins (PV) are covered by myocardium 
derived from the posterior heart field (dark blue). In the area between the PVs the myocardium can be 
discontinuous or absent. The right atrial body (RAB) is covered by sinus venosus myocardium (light blue). 
b. The inner aspect of both LAB and RAB is smooth-walled. In the LAB vessel wall tissue (red) is found. The 
left and right atrial appendages (LAA, RAA) consist of trabeculated myocardium (brown).
c,d. TAPVC, extracardiac type. The PVs drain via a vertical vein (VV) into a systemic vein (SV) and are not 
covered by myocardium. The LAB consists of smooth-walled hypoplastic myocardium, derived from the 
posterior heart field. Because of the absence of a PV connection and incorporation into the LA, the LAB is 
small. Moreover, the LAB does not contain vessel wall tissue, probably because of impaired differentiation 
of smooth muscle cells.
e,f. PAPVC, cardiac type. The abnormally connected PV drains directly into the right atrial body (RAB), 
but (as in the normal situation) no vessel wall tissue is found in the RAB. In contrast to the PVs that are 
connected to the LAB, the abnormal PV is not covered by myocardium.
g,h. PAPVC, extracardiac type. The abnormally connected PV drains (in)directly into the superior caval vein 
(SCV) and is, similar to the cardiac type of PAPVC, not covered by myocardium. The LAB and its incorporated 
PVs are myocardialized and, also comparable to the normal heart, vessel wall tissue is present in the LAB. 
i,j. Situs inversus. The LAB is located on the right side of the heart and receives the four PVs, which are 
covered by myocardium. In the LAB vessel wall is found parallel to normal PV incorporation.
Coronary sinus (CS), inferior caval vein (IVC), pulmonary venous confluence (PVC). Modified after Douglas 





































TAPVC and genetics. Maternal exposure to environmental teratogens as lead, paint 
or pesticides have been described to cause a familial susceptibility for TAPVC, 
mostly in the presence of a positive family history of cardiac and non-cardiac 
malformations80,81. Until now, familial incidence of TAPVC appeared not to be related 
to ethnic background and was seen in siblings, twins and cousins of the same family 
with a male preponderance80,82. Moreover, TAPVC has been described in association 
with genetic syndromes, such as the Holt-Oram syndrome, cat eye syndrome and 
craniofacial and skeletal dysmorphias80,83, so that the question has raised whether 
there is a heritable component. Since then, various genetic hypotheses have been 
proposed. Multifactorial inheritance84 seemed unlikely in families with two or 
more positive members, as well as autosomal recessive inheritance in the absence 
of consanguinity in positive families85. More likely is an X-linked inheritance86 and 
autosomal dominance with variable expressivity and incomplete penetrance83,87. As 
beforementioned, in 70-80% of patients with the asplenia syndrome TAPVC is the 
most characteristic heart defect78. Both of these laterality disorders are suggested 
to be different expressions of a single genetic disorder78. Because of scarcity of 
multigeneration TAPVC families, identification of candidate genes for TAPVC is 
difficult. Until now, two candidate genes have been proposed. The TAPVR1 gene, 
playing a role in vasculogenesis, maps to chromosome 4q12, which centromeric 
region contains receptor tyrosine kinase genes as kinase domain receptor (KDR)88. 
Recently, the TAPVR1 susceptibility locus was specified to the PDGFRA-KIT intergenic 
interval of chromosome 4q1248. The ANKRD1/CARP gene, encoding a cardiac 
transcriptional regulator, was localized proximally to the breakpoint of a previously 
found translocation site on chromosome 1089,90. Investigations to limit the TAPVR1 
gene interval and specify the role of the CARP gene in the pathogenesis of TAPVC are 
on their way.
Another unsolved issue is the etiology of primary PV stenosis. Until now, in literature, 
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3.1.2. PAPVC.   
In this condition, two or more PVs connect normally to the LA and two or less PVs 
do not lumenize or become atretic after initial lumenization. The corresponding 
lung(segment) drains its blood to the systemic venous circulation, usually extracardially 
by means of persistence of connections to the superior caval vein (Fig.4b) or to the 
inferior caval vein (Scimitar syndrome91). However, two or more PVs can also connect 
cardially, i.e. to the sinus venosus part of the right atrium, which is the consequence 
of defective mesenchymal contribution to atrial septation, obligatory coexisting with 
a sinus venosus defect14 (section 3.1.5).
3.1.3. Cor triatriatum.   
This condition is based on stenosis of the common PV, leading to non-incorporation 
(Table 1). The PVs connect to a separate chamber that either drains to the left or 
(rarely) to the right atrium, dependent on initially normal or abnormal connection 
of the common PV92. The LA body is very small due to absence of PV incorporation. 
Moreover, cor triatriatum in combination with left or right atrial isomerism can be 
found70. 
3.1.4. PV stenosis.   
This condition can be congenital or acquired93.
3.1.4.1 Primary PV stenosis.   
This is the consequence of abnormal remodeling of individual PVs. It can be found 
in hearts with normally94 as well as abnormally connected PVs95. The stenosis can 
be present in either all the PVs, or in individual PVs, localized either at the veno-
atrial transition or more peripherally towards the lung. In hearts with normal PV 
connection, the PV return to the LA will be obstructed, whereas in case of anomalous 
PV connection, pulmonary venous return to the right atrium is obstructed. Both 




































3.1.4.2. Acquired PV stenosis.   
Whereas the exact etiology of congenital PV stenosis is unknown, acquired PV 
stenosis can be the consequence of radiofrequency ablation96, surgery97,98 or by a so-
called pulmonary veno-occlusive disease99,100. Pulmonary veno-occlusive disease is 
characterized by extensive and diffuse occlusion of PVs by fibrous tissue. Usually the 
(eccentric) intimal thickening involves venules and small veins but, occasionally, also 
larger veins are involved. Clinically, patients have pulmonary arterial hypertension 
without elevation of the pulmonary arterial wedge pressure. Infectious, genetic, and 
toxic agents as well as a thrombotic diathesis and autoimmune disorders may be 
responsible for the etiology of pulmonary veno-occlusive disease99,100.
3.1.5. Sinus venosus superior or inferior defect.   
Normally, during atrial septation, mesenchyme of the dorsal mesocardium protrudes 
in the dorsal wall of the primary atrial segment (dorsal mesenchymal protrusion12 
or spina vestibuli13) being responsible for leftward displacement of the common PV. 
When this mesenchymal contribution to atrial septation from the posterior heart 
field is impaired, a so-called sinus venosus defect can develop, often resulting 
in anomalous connection of one or two right PVs (PAPVC) to the right-sided sinus 
venosus: the sinus venarum of the right atrium, one of the atrio-caval junctions or 
the superior or inferior caval vein14. Similarly, severe hypoplasia of this DMP (may) 
lead to TAPVC to the sinus venosus part of the right atrium (cardiac type)48.
3.1.6. Variant number of PVs.   
This condition is based on variations in PV incorporation which can be caused by 
PV stenosis at the veno-atrial junction. Incomplete PV incorporation can result in 
a unilateral common PV ostium, mostly seen on the left side15,16,101. Extreme PV 
incorporation can lead to more than four PV ostia, more frequently seen on the 
right side as an additional right PV draining the right middle lung lobe16 (Table 1). 
In our opinion, both common ostia and additional PVs should not be regarded as an 
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4. How is PV development related to arrhythmogenesis?
4.1. Normal PV development.   
The majority of atrial paroxysms of arrhythmia start with earliest activation at the 
PV ostium or within the PVs1. Characteristics of the PV myocardial sleeves are held 
responsible for this potential to generate arrhythmias. These myocardial sleeves 
are thickest at the veno-atrial junction and become thinner peripherally, towards 
the lung101,102. The myocardial architecture in normal PVs is highly variable102. 
Usually, the sleeves are better developed in the superior than in the inferior PVs, 
specifically at the inferior side of the superior PVs and at the superior side of the 
inferior PVs53,102. At the endocardial (inner) side of the vessel a circumferentially 
oriented myocardial fibre arrangement is described, while at the epicardial (outer) 
side this arrangement is longitudinally103. These transitions in fibre arrangement in 
combination with interpositions of fibrous tissue, separating myocardial fibres, can 
lead to activation delay and conduction block, so creating a milieu for reentry102,104. 
Another predisposing factor to reentry in normal development may be the myocardial 
discontinuity in the area between the PVs, as well as in the transitional zone between 
the LA body and the LA appendage15. 
Next to these architectural characteristics of the PVs, several other mechanisms 
may contribute to the arrhythmogenic capacities of the PVs. Morphologic studies 
have described cells resembling pacemaker cells in the myocardium surrounding the 
PVs105,106. These observations would explain the possible independent pacemaker 
activity that was observed in the PVs in otherwise mechanical silent hearts of rabbits 
and cats, described as early as 1874. It is tempting to speculate that the presence 
of node-like cells would also be responsible for the initiations of paroxysms of atrial 
arrhythmias described later on1.
In this light, it is interesting to note that several immunohistochemical and molecular 
markers related to the developing cardiac conduction system are (transiently) 
expressed in the myocardium surrounding the developing PV, including HNK-1, CCS-
LacZ, and podoplanin, suggesting that areas related to the occurrence of arrhythmias 
correspond to areas derived from the embryonic cardiac conduction system32,35. It 
was hypothesized that embryonic remnants or re-expression of embryonic genes 




































These findings are strengthened by several electrophysiological studies that have 
demonstrated specific electrophysiological capacities of the PVs as compared to the 
atria107-109, with a reduced resting membrane potential, action potential amplitude, 
a smaller phase 0 upstroke velocity and a shorter duration of the action potential 
resulting in shorter refractory periods and slowed conduction. These cellular 
characteristics in combination with the anisotropic arrangement of the PV myocardial 
fibres favour the occurrence of reentry and probably the maintenance of initiated 
arrhythmias103,104.
Furthermore, spontaneous or enhanced pacemaker activity (abnormal automaticity) 
in the PVs has been reported110,111. 
Recently, human genetics studies identified two sequence variants on chromosome 
4q25 that were strongly associated with increased risk for atrial fibrillation112. The 
gene closest to these sequence variants is Pitx2, which is critical for the development 
of PV myocardium, making Pitx2 a likely candidate locus for atrial fibrillation112,113. 
Moreover, the presence of a sequence variant increased the risk for both early and 
late recurrence of atrial fibrillation114.
4.2. Abnormal PV development.   
In patients with TAPVC, conduction abnormalities, including sinus node dysfunction 
(sick sinus syndrome, tachy- and bradyarrhythmia) are reported115-117. In hearts with 
TAPVC, the PVs lack a myocardial sleeve and the myocardium of the LA dorsal wall 
is hypoplastic, with discontinuities67. The combination of hypoplastic myocardium 
and sinus node dysfunction could be related to an abnormal contribution from 
the posterior heart field, as studies in podoplanin knockout mice demonstrate 
both hypoplastic and discontinuous myocardium surrounding the PVs, as well as 
an hypoplastic sino-atrial node36,49. Hypoplasia of the sinus node in TAPVC would 
provide a plausible explanation to the observed conduction disorders in TAPVC. 
However, further research is needed to reveal a possible co-existence of pulmonary 
venous myocardial hypoplasia and hypoplasia of the sinus node in TAPVC67. Although 
myocardial discontinuities of the LA dorsal wall could form a substrate for generation 
of arrhythmias in TAPVC hearts, total absence of a PV myocardial sleeve may explain 
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After surgical repair of TAPVC, compared to other atrial surgery, significant atrial 
arrhthymias as atrial flutter and reentry tachycardias are uncommon, although 
sinus node dysfunction (sick sinus syndrome, tachy- and bradyarrhythmia) has been 
reported115-117.
In general, in this patient group, arrhythmias are asymptomatic and not related to the 
type of surgery118 (and Douglas et al. unpublished results). Therefore, it is arguable 
whether the reported arrhythmias are related to the operation or to the pathological 
findings of TAPVC itself. Given the possible relation with sinus node dysfunction, for 
this patient category a careful follow-up including Holter registration is warranted.
5. What are consequences of the various concepts of PV development on clinical 
management?
For surgical correction of TAPVC, the PV confluence has to be connected to the LA. 
This can be performed by an anteroposterior right-to-left atrial incision after median 
sternotomy, or by a single LA incision after a left lateral thoracotomy. Subsequently, 
an anastomosis is made between the PV confluence and the LA after ligation of the 
former connection to the systemic circulation, the vertical vein. Since the LA in TAPVC 
is very small67, in the past, surgeons have tried to augment the LA with a patch, 
however this appeared to be the substrate for arrhythmias95,98. In hearts with TAPVC, 
the PVs have no myocardial layer resulting in an enhanced susceptibility for internal 
and environmental influences making them more prone to congenital and acquired 
PV stenosis93,96, which is still one of the main unravelled problems. For postoperative 
PV stenosis at the site of the anastomosis surgeons successfully developed and 
applied so-called sutureless techniques, leaving the PVs untouched119,120. Primary PV 
stenosis is still a major cause of death in this patient group97,98. 
In PAPVC, frequently presenting as part of a sinus venosus defect, drainage of the 
abnormally connecting PVs has to be “rerouted” to the LA which usually is performed 
by an atrial patch that is fixed around the abnormally connecting PV ostia, so directing 
drainage to the LA. If this is anatomically not possible, the PVs have to be reimplanted 
in the LA. Surgery of one abnormally connecting PV usually will not be performed 




































In hearts with normal as well as abnormal PV connections, myocardial discontinuities 
are found in the LA dorsal wall, which can form a substrate for the onset of 
arrhythmias15,67. Interventional cardiologists performing ablational techniques for 
these arrhythmias should be aware of the increased vulnerability to damage of these 
areas in the LA where a myocardial wall is lacking, specifically in the proximity of 
the esophagus. Recent studies have emphasized the risk of atrio-esophageal fistula 
due to the application of radiofrequency current at this site121,122. Lower dosage of 
radiofrequency current is therefore recommended when ablating in this area.
Future perspectives and conclusions.
In this review normal and abnormal PV development is described and updated 
based on the current literature. We have described how normal PV development 
starts with lumenization of a midpharyngeal endothelial strand, that provides a 
connection to the endocardium of the heart right from early development on. 
Although discussion on whether the primitive PV after lumenization drains into the 
atrial segment or the sinus venosus segment of the heart is still ongoing, based on 
the results of our studies, we favour an original connection of the primitive PV to 
the sinus venosus segment of the heart. From the posterior heart field, as part of 
the second heart field, SMCs and myocardial cells are contributed to the PV and 
LA dorsal wall. Normally, pulmonary-to-systemic connections disappear during 
development. Abnormal PV development may lead to persistence of pulmonary-to-
systemic connections which is a substrate of anomalous PV connection(s), related to 
different clinical entities. In normal PV development the myocardium surrounding 
the PVs has specific characteristics creating a milieu for arrhythmias and reentry. In 
abnormal PV development, we hypothesize that rhythm- or conduction disorders 
might be explained in some patients by an insufficient contribution of posterior heart 
field myocardium to the sinus node and LA dorsal wall.
Surgical procedures have been developed to correct anomalous PV connections and 
to manage surgery-related complications.
There are still a number of topics that remain unresolved and have to be addressed 
by future research. Additional cell tracing studies are necessary to unequivocally 
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With regard to arrhythmia treatment, currently mainly conventional anti-arrhythmic 
therapies and ablational strategies have been applied to control atrial arrhythmias. 
Development of new ablation techniques, and the expanding possibilities to integrate 
imaging techniques with electrophysiological mapping data and genetic data will 
improve patient selection and selectivity of application sites in order to decrease 
the recurrence rate of the arrhythmias114,123. Acquired PV stenosis as a consequence 
of surgical correction or resulting from ablation therapy needs further improvement 
of surgical techniques and refinement of useful energy sources. Pre-interventional 
imaging by echocardiography or computed tomography may also helpful in localizing 
areas at risk and preventing this potentially serious disorder.
The underlying mechanisms leading to primary PV stenosis are still unknown. Future 
investigation of a potential genetic basis is an important next step in understanding 
and manipulating this serious disease. 
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In Chapter 1 the necessity of knowledge of general cardiac development for a proper 
understanding of normal and abnormal pulmonary vein development is emphasized. 
A general overview of cardiac and pulmonary vein development is provided as well as 
an overview of the development of the cardiac conduction system, since (ab)normal 
pulmonary vein development and the potency for development of atrial arrythmias 
are embryonically related. Under certain circumstances, initially non-functional 
embryonic deposited cardiac conduction cells are supposed to be reactivated and to 
contribute to the onset of arrhythmias.
Different heart fields are discriminated that contribute to the formation of the final 
heart. The first heart field forms the primitive heart tube that consists of a small 
atrial segment, an atrioventricular canal and a primitive left ventricle. The second 
heart field consists of an anterior heart field that contributes cells for the formation 
of the right ventricle and the proximal outflow tract, a secondary heart field, that 
contributes cells for the distal outflow tract, and a posterior heart field from which 
cells are derived for the development of the atria, the cardiac conduction system, 
and the sinus venosus, including the sino-atrial node, the pulmonary veins, the 
cardinal veins and the coronary sinus. Since this thesis deals with pulmonary vein 
development this posterior heart field is our main region of interest. 
With regard to abnormal pulmonary vein development in relation to clinical entities 
it is emphasized that heart malformations are mostly the result of highly complex 
cascades of gene interactions combined with epigenetic factors that cannot be 
simply deduced to isolated clinical entities.
In Chapter 2 the histology of the left atrial wall in relation to the incorporation of the 
pulmonary veins is studied immunohistochemically in sixteen human embryos and 
fetuses, one neonate and five adults. Based on histological criteria, three different 
compartments can be distinguished in the left atrium: 1. the smooth-walled left atrial 
body with vessel wall tissue, which is histologically identical to the vessel wall of 
the incorporated pulmonary veins, 2. the trabeculated left atrial appendage without 
vessel wall tissue and 3. a transitional zone in between the left atrial body and the left 
atrial appendage which is smooth-walled, lacks vessel wall tissue and histologically 





































zone is hypothesized to be the left part of the embryonic sinus venosus, that has 
shifted to the left due to incorporation of the pulmonary veins. Furthermore, areas 
of discontinuous or even absent myocardium are demonstrated in between the 
pulmonary veins and in the transitional zone. These areas are probably the substrate 
for arrhythmias. Besides that, the left atrial wall is supposed to be vulnerable to 
damage because of this myocardial discontinuity and the fact that in case of ablation 
strategies the histological border between the left atrium and the pulmonary veins 
cannot be found.
In Chapter 3 we compare the development and differentiation of the myocardium and 
vascular wall of the pulmonary veins, the left atrial dorsal wall and the atrial septum 
in wild type with podoplanin knockout embryos (E10-E18.5) by 3D reconstruction 
and immunohistochemistry and demonstrate that in mutants, the myocardium of 
the pulmonary veins, the left atrial dorsal wall and the atrial septum is hypoplastic 
and that extension of smooth muscle cells into the left atrial body is diminished. 
Since podoplanin is a marker of myocardial and mesenchymal cells derived from 
the posterior heart field, we conclude that the myocardium of the pulmonary veins, 
the dorsal atrial wall and the atrial septum, as well as the smooth muscle cells are 
derived from the posterior heart field, regulated by podoplanin. We state that more 
insight in the variation in myocardial cuffing of the pulmonary veins might enlighten 
us on the variability of the occurrence of ectopic automaticity in the pulmonary vein 
myocardial sleeve.
In Chapter 4 we investigate the wall of the pulmonary veins and the left atrial 
body in ten human neonates with total anomalous pulmonary venous connection 
(TAPVC), using histological and immunohistochemical techniques. As controls, two 
normal neonatal and adult hearts and five neonatal hearts with partial anomalous 
pulmonary venous connection (PAPVC) or situs inversus are studied. We demonstrate 
that in hearts with TAPVC, the left atrial body is small, lacks vessel wall tissue 
and has a hypoplastic myocardial layer. No myocardial layer is formed around the 
pulmonary veins. In hearts with PAPVC, only the non-left atrial draining pulmonary 




































veins connecting to the right-sided left atrium are normally myocardialized. Based on 
these results, we conclude that recruitment of cells, for addition of myocardium and 
smooth muscle cells at the venous pole, mainly takes place from the morphological 
left side. Moreover, we state that an open connection of the pulmonary veins with 
the morphological left atrium is mandatory for a normal left atrial size, the presence 
of vessel wall tissue and myocardialization of the left atrial body and pulmonary veins. 
Absence of myocardium covering the pulmonary veins is hypothesized to enhance 
susceptibility to pulmonary vein stenosis and to prevent the onset of pulmonary 
vein originating arrhythmias. As a link to chapter 3, we postulate that the embryonic 
posterior heart field might be responsible for the abnormal myocardialization and 
smooth muscle cell formation in TAPVC.
In Chapter 5 a clinical case with right-sided pulmonary vein stenosis together with 
a left-sided pulmonary varix is embryologically and hemodynamically unravelled. A 
pulmonary varix is a dilated and tortuous pulmonary vein resulting from congenital 
or acquired obstruction of pulmonary vein drainage. In this case, we deal with a 
combination of congenital and acquired pulmonary vein stenosis on the right side 
and a congenitally formed pulmonary varix on the left. The difficulty and importance 
to determine whether the pulmonary vein stenosis is congenital or acquired, is 
emphasized.
In conclusion in Chapter 6 current opinions on normal and abnormal pulmonary vein 
development in relation to clinical (management of) diseases are presented, based 
on the literature. This review serves as a general discussion of the contents of this 
thesis. Several questions are addressed as well as conceptual controversies. A general 
overview of cardiac development is provided, followed by definitions of the different 
components of the venous pole, the role of the second heart field at the venous 
pole, developmental concepts on the origin of normal and abnormal pulmonary vein 
drainage, the relation of pulmonary vein development to arrhythmogenesis and the 
consequences of the various concepts of pulmonary vein development on clinical 





































In Hoofdstuk 1 wordt het belang van het vergaren van kennis over de algemene hart 
ontwikkeling voor een goed begrip van normale en abnormale pulmonaalvenen 
(longader) ontwikkeling benadrukt. Er wordt een algemeen overzicht gegeven van 
de hart en pulmonaalvenen ontwikkeling. Aangezien (ab)normale pulmonaalvenen 
ontwikkeling en de potentie om atriale ritmestoornissen te ontwikkelen embryonaal 
aan elkaar zijn gerelateerd, wordt eveneens een overzicht gegeven van de ontwikkeling 
van het geleidingssysteem van het hart. Onder bepaalde omstandigheden, kunnen 
embryonaal ontstane geleidingssysteem eigenschappen in tot dan toe niet-
functionele geleidingssysteem cellen gereactiveerd worden en bijdragen aan het 
ontstaan van ritmestoornissen.
Er kunnen verschillende “heart fields” worden onderscheiden die bijdragen aan de 
vorming van het volgroeide hart. Het zogenaamde first of primary heart field vormt 
de primitieve hartbuis, die bestaat uit een klein atriaal (boezem) segment, een 
atrioventriculair kanaal en een primitieve linker ventrikel (kamer). Het zogenaamde 
second heart field bestaat uit een anterior heart field dat bijdraagt aan de vorming 
van de rechter ventrikel en het aansluitende eerste deel van het uitstroomsegment, 
een secondary heart field, dat cellen aanlevert voor het laatste deel van het 
uitstroomsegment, en een posterior heart field van waaruit cellen verkregen worden 
voor de ontwikkeling van de atria, het geleidingssysteem van het hart en de sinus 
venosus, waaronder de sinusknoop, de pulmonaalvenen, de cardinaalvenen en de 
sinus coronarius vallen. Aangezien dit proefschrift gaat over de ontwikkeling van de 
pulmonaalvenen, is dit laatstgenoemde posterior heart field het gebied van focus van 
dit proefschrift. 
Wat betreft abnormale pulmonaalvenen ontwikkeling in relatie tot specifieke 
klinische aandoeningen, moet benadrukt worden dat hartafwijkingen meestal 
de resultante zijn van zeer complexe cascades van geninteracties gecombineerd 
met omgevingsfactoren van waaruit deze specifieke klinische aandoeningen niet 
eenvoudigweg herleidbaar zijn.
In Hoofdstuk 2 wordt de histologie van de linker atriumwand in relatie tot de 
incorporatie van de pulmonaalvenen immunohistochemisch bestudeerd in zestien 




































op histologische criteria, kunnen drie verschillende compartimenten worden 
onderscheiden in het linker atrium: 1. het gladwandige corpus van het linker atrium 
bekleed met vaatwand weefsel, histologisch identiek aan de vaatwand van de 
geincorporeerde pulmonaalvenen, 2. het getrabeculariseerde linker hartoor zonder 
vaatwand weefsel, en 3. een gladwandige overgangszone tussen het corpus van het 
linker atrium en het linker hartoor, zonder vaatwand en histologisch erg lijkend op 
het weefel van de sinus venarum (het corpus) van het rechter atrium. Verondersteld 
wordt dat deze overgangszone het linkszijdige deel van de embryonale sinus venosus 
is, die ten gevolge van de incorporatie van de pulmonaalvenen is “opgeschoven” naar 
de overgang met het linker hartoor. Daarnaast wordt aangetoond, dat zowel in het 
gebied tussen de pulmonaalvenen als in de genoemde overgangszone, het myocard 
plaatselijk discontinu of zelfs afwezig is. Deze plekken kunnen het substraat voor 
atriale ritmestoornissen zijn en kunnen bovendien de linker atriumwand kwetsbaar 
maken voor beschadiging. Het feit dat, tijdens ablatie technieken, de histologische 
grens tussen het linker atrium en de pulmonaalvenen niet zichtbaar is, maakt de 
linker atriumwand extra kwetsbaar.
In Hoofstuk 3 vergelijken we, met behulp van 3D reconstructies en 
immunohistochemische technieken, de ontwikkeling en differentiatie van het 
myocard en de vaatwand van de pulmonaalvenen, de linker atrium achterwand en 
het atrium septum in wild type muizen embryo’s met die van podoplanine  knockout 
muizen embryo’s (E10-E18.5). We tonen aan dat in mutanten, het myocard van de 
pulmonaalvenen, de linker atrium achterwand en het atrium septum hypoplastisch 
is en dat bovendien de aanwezigheid van gladde spiercellen in het corpus van het 
linker atrium verminderd is. Aangezien podoplanine  een marker is voor myocardiale 
en mesenchymale cellen afkomstig uit het posterior heart field, concluderen we 
dat zowel het myocard van de pulmonaalvenen, de linker atrium achterwand en 
het atrium septum als de gladde spiercellen, afkomstig zijn uit dit posterior heart 
field, gereguleerd door podoplanine. We stellen vast dat meer inzicht in variatie in 
myocardiale bekleding van de pulmonaalvenen ons opheldering zou kunnen geven 
over de variabiliteit in het ontstaan van ectopische automaticiteit in deze myocardiale 





































In Hoofdstuk 4 onderzoeken we de wand van de pulmonaalvenen en het linker 
atrium in tien humane neonaten met totaal abnormale pulmonaalvenen connectie 
(TAPVC), gebruik makend van histologische en immunohistochemische technieken. 
Ter controle worden twee normale humane neonatale en volwassen harten en 
vijf humane neonatale harten met partieel abnormale pulmonaalvenen connectie 
(PAPVC) of situs inversus bestudeerd. We stellen vast dat in harten met TAPVC, 
het corpus van het linker atrium onderontwikkeld is, geen vaatwand bevat en uit 
hypoplastisch myocard bestaat. Een myocardiale laag rond de pulmonaalvenen wordt 
niet aangelegd. In harten met PAPVC, ontbreekt de myocardiale laag alleen rond de 
pulmonaalvene die niet naar het linker atrium draineert, terwijl in harten met situs 
inversus, pulmonaalvenen die verbonden zijn met het rechtsgelegen linker atrium 
normaal gemyocardialiseerd zijn. Gebaseerd op deze resultaten, concluderen we 
dat de rekrutering van cellen, voor aanbouw van myocard en gladde spiercellen ter 
plaatse van de veneuze pool, hoofdzakelijk plaats vindt vanuit de morfologisch linker 
kant van het posterior heart field. We stellen bovendien vast, dat een open connectie 
van de pulmonaalvenen met het morfologische linker atrium een voorwaarde is 
voor het ontwikkelen van een normale linker atrium grootte, de aanwezigheid 
van vaatwand weefsel in het linker atrium en een normale myocardialisatie van 
het corpus van het linker atrium en de pulmonaalvenen. We veronderstellen, dat 
de afwezigheid van myocard rond de pulmonaalvenen de kwetsbaarheid van de 
pulmonaalvenen voor het ontstaan van pulmonaalvenen stenose verhoogt, en 
tegelijkertijd het ontstaan van ritmestoornissen, afkomstig uit de pulmonaalvenen, 
voorkomt. In combinatie met de opgedane kennis in hoofdstuk 3, constateren we, 
dat het embryonale posterior heart field verantwoordelijk zou kunnen zijn voor de 
abnormale myocardialisatie en de abnormale vorming van gladde spiercellen in 
TAPVC harten.
In Hoofdstuk 5 wordt een klinische casus met rechtszijdige pulmonaalvenen 
stenose gepaard gaande met een linkszijdige pulmonale varix embryologisch en 
hemodynamisch onder de loep genomen. Een pulmonale varix is een aangeboren 
of verworven spatader in de long die kan ontstaan ten gevolge van een belemmerde 




































congenitale en verworven pulmonaalvenen stenose rechts en een congenitaal 
ontstane pulmonale varix links. De complexiteit en het belang van het vaststellen 
of de pulmonaalvenen stenose congenitaal danwel verworven is, wordt benadrukt.
We eindigen in Hoofdstuk 6 met de huidige opinie over normale en abnormale 
pulmonaalvenen ontwikkeling in relatie tot klinische (behandeling van) ziekten, 
gebaseerd op de literatuur. Dit review dient als algemene discussie voor de inhoud 
van dit proefschrift. Verscheidene vragen worden behandeld en beantwoord evenals 
conceptuele controverses. Er wordt een algemeen overzicht van de hart ontwikkeling 
gegeven, gevolgd door definities van de verschillende componenten van de veneuze 
pool, de rol van het second heart field ter plaatse van de veneuze pool, concepten 
over de ontwikkeling van normale en abnormale pulmonaalvenen drainage, de relatie 
van pulmonaalvenen ontwikkeling tot arrhythmogenese en de consequenties die de 
verscheidene concepten over pulmonaalvenen ontwikkeling hebben voor klinisch 
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In de afgelopen zeven jaar, waarin ik eens per twee weken op dinsdag voor mijn 
onderzoek afreisde naar Leiden, zijn vele mensen behulpzaam geweest bij het tot 
stand komen van dit proefschrift. Een aantal van hen wil ik in het bijzonder noemen.
Margot Bartelings, door je innemende persoonlijkheid voelde ik me al snel heel 
vertrouwd met je. Meelevend in goede en slechte tijden. Niet voor niks ben je 
mijn paranimf vandaag! Samen hebben we vele hartjes bekeken, stukjes weefsel 
uitgenomen en vervolgens gediscussieerd over hoe het volgens ons allemaal zat, een 
gedeelde passie! Dank voor al je tijd. Nederland mag zuinig zijn op iemand van jouw 
kaliber en met jouw expertise.
Edris Mahtab, door je enthousiasme, optimisme en intelligentie was het een plezier 
om met je samen te werken. Dank voor jouw bijdrage aan ons gezamenlijke artikel! 
Wat geweldig dat je je felbegeerde opleidingsplaats thoraxchirurgie hebt bemachtigd, 
je hebt het verdiend! 
De medewerkers van het laboratorium voor Anatomie en Embryologie te Leiden: 
Monica Mentink, Conny van Munsteren en Jan Leeflang: ik ben jullie zeer dankbaar 
voor jullie hulp betreffende het snijden en kleuren van de coupes. Hierdoor kon ik 
iedere keer wanneer ik in Leiden was mijn tijd zo efficiënt mogelijk benutten. 
Bert Wisse, Jan Lens en Ron Slagter, jullie zijn verantwoordelijk geweest voor het zo 
professioneel vervaardigen van de vele figuren en de 3D reconstructies. Hierdoor is 
dit proefschrift rijk geïllustreerd met prachtige plaatjes!
De dames van het secretariaat Joke van Benten en Anne Marie de Wit en 
Wies Groeneboer: dank voor jullie gastvrijheid, het regelen van sleutels, 
medewerkerspassen etc. Mede door jullie bleef ik op de hoogte van de belangrijke 
zaken en had ik het gevoel er echt bij te horen.
Rebecca Vicente Steijn, Noortje Bax, Heleen Lie-Venema, Anastasia Egorova en 
Nynke van den Akker: dank voor jullie belangstelling, behulpzaamheid en het delen 
van ervaringen. Ondanks het feit dat ik er maar zo weinig was waren jullie onderdeel 
van mijn vertrouwde werkomgeving in Leiden.
Daniël Jansma en Paul Gobée: jullie zijn behulpzaam en denken niet in problemen 





































Vervolgens mijn collega’s uit het UMCG in Groningen. 
Allereerst wil ik noemen Margreet Bink-Boelkens, kindercardiologe. Wij hadden een 
eigen TAPVC mini-databank en bekeken en analyseerden vele Holters. Ook al leidde 
het niet tot een publicatie vanwege te kleine aantallen, de opgedane kennis kwam 
later van pas bij mijn nieuwe bevindingen. Jij hebt me met Adri in contact gebracht 
waarvoor dank. Je bleef altijd geïnteresseerd en ik vind het daarom extra leuk dat je 
in mijn leescommissie plaats hebt willen nemen!
Mijn thoraxchirurgische collega’s Michiel Erasmus, Inez den Hamer, Theo Klinkenberg, 
Koos Meuzelaar, Ehsan Natour, Michael Hartman, Jan Eikelaar, Tjalling Waterbolk, 
Tjark Ebels, Yvonne Drijver en Massimo Mariani: dank voor jullie vertrouwen dat het 
wel een keer goed zou komen met “het boek”. 
Het secretariaat Jessica Volders, Anneke Hamming, Stefanie van der Veen, Daniëlle 
Groenhagen, Sylvia Germes en Marja Okken: Dank voor de bereidheid mij in de 
oneven weken op dinsdag uit te roosteren en afdelingen te informeren omtrent het 
tijdstip van het preoperatieve gesprek met de patiënten. Magda Munstra en Alma 
Guikema, ik dank jullie voor de hulp bij het verzamelen van alle adressen!
Mijn lieve vriendinnen en vrienden. Dank voor de jarenlange en voortdurende 
vriendschap, die ik koester, ook al kan ik niet altijd van de partij zijn. Onze 
gemeenschappelijke etentjes, vakanties, uitjes en gezellige avondjes zijn goud waard. 
Lieve pap en mam, Marcelle, Robin en Alexandra, Eliane en Erik, inclusief kinderen, 
dank voor jullie onvoorwaardelijke steun en rotsvaste vertrouwen in mij!
Mijn lieve stoere kinderen Frits, Pien en Jur, jullie vonden het eigenlijk nooit zo leuk 
wanneer ik ’s avonds vertelde de volgende dag weer naar Leiden te gaan. Toch waren 
en zijn jullie altijd betrokken gebleven bij wat ik doe en zijn jullie steeds nieuwsgierig 
geweest naar het resultaat. Fantastisch, ik ben heel trots op jullie!








































De auteur van dit proefschrift is geboren op 16 maart 1964 te Amsterdam. In 1982 
deed zij eindexamen Atheneum-B aan de Openbare Scholengemeenschap Erasmus 
te Almelo. In 1982 startte zij met de studie Geneeskunde aan de Rijksuniversiteit van 
Groningen. In 1986 behaalde zij haar doctoraal examen en in 1989 het artsexamen. 
Vervolgens werkte zij van 1989 tot 1992 als AGNIO Interne Geneeskunde, 
Neurologie, Chirurgie en Plastische Chirurgie. Na tevens ruim een jaar ervaring te 
hebben opgedaan als AGNIO Cardio-thoracale chirurgie in Groningen startte zij 
aldaar in 1993 met haar opleiding tot Cardio-thoracaal chirurg (opleiders Prof. Dr. R. 
van Schilfgaarde en Prof. Dr. T. Ebels), welke op 1 maart 2000 werd voltooid. Tijdens 
haar opleiding werden haar zoon Frits (1996) en dochter Pien (1998) geboren en na 
haar opleiding haar jongste zoon Jur (2001). Sinds maart 2000 is zij werkzaam als 
staflid Cardio-thoracale chirurgie te Groningen met een speciale belangstelling voor 
de Congenitale hartchirurgie en Anatomie. Dit resulteerde in 2003 in het starten van 
basaal onderzoek naar de ontwikkeling van de pulmonaalvenen en de linker atrium 
achterwand en naar abnormale longvenendrainage onder leiding van Prof. Dr. A.C. 
Gittenberger-de Groot in het laboratorium voor Anatomie en Embryologie te Leiden. 
De resultaten hiervan staan beschreven in dit proefschrift.
Als Cardio-thoracaal chirurg houdt zij zich momenteel bezig met de volwassen Cardio-
thoracale chirurgie met als aandachtsgebieden de mitraalklep- en aorta(wortel)
chirurgie en de transapicale aortaklep chirurgie. In de toekomst wil zij daarnaast 
meer organisatorische taken op zich nemen en hoopt zij haar wetenschappelijke 
activiteiten te verleggen naar Groningen. Daarnaast zou zij ook graag betrokken 
blijven bij de huidige onderzoekslijn op pulmonaalvenen gebied in Leiden. 


